Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

___________________________________

FORM 10-Q

___________________________________

(Mark One)


x			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2023


o			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______ to _______

Commission File Number 001-41043

___________________________________

Expensify, Inc.

___________________________________

(Exact name of registrant as specified in its charter)


Delaware			27-0239450
(State or other jurisdiction of incorporation or organization)			(I.R.S. Employer Identification No.)
401 SW 5th Ave Portland, Oregon			97204
(Address of Principal Executive Offices)			(Zip Code)

(971) 365-3939

Registrant’s telephone number, including area code

___________________________________

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Class A Common Stock, par value $0.0001 per share

EXFY

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period

that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.


Large accelerated filer	x	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes o No x

The registrant had outstanding 68,420,787 shares of Class A common stock, par value of $0.0001 per share, 7,333,619 shares of LT10 common stock, par value $0.0001 per share, and 7,093,750 shares of LT50 common stock, par value $0.0001 per share, as of August 4, 2023.

Table of Contents


		Page
Special Note Regarding Forward-Looking Statements

Part I - Financial Information
Item 1.	Condensed Consolidated Financial Statements	1
	Condensed Consolidated Balance Sheets	2
	Condensed Consolidated Statements of Operations	3
	Condensed Consolidated Statements of Changes in Stockholders’ Equity	4
	Condensed Consolidated Statements of Cash Flows	8
	Notes to Condensed Consolidated Financial Statements	9
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	23
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	37
Item 4.	Controls and Procedures	37

Part II - Other Information
Item 1.	Legal Proceedings	38
Item 1A.	Risk Factors	38
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	38
Item 3.	Defaults Upon Senior Securities	39
Item 4.	Mine Safety Disclosures	39
Item 5.	Other Information	39
Item 6.	Exhibits	40
	Signatures

Table of Contents

Special Note Regarding Forward Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements about us and our industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q, including statements regarding our strategy, future financial condition, future operations, projected costs, prospects, plans, objectives of management and expected market growth, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “may,” “will,” “shall,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” “goal,” “objective,” “seeks,” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategies, plans, or intentions. There are a number of risks, uncertainties and other important factors, many of which are beyond our control, that could cause our actual results to differ materially from the forward-looking statements contained in this Quarterly Report on Form 10-Q. Such risks, uncertainties and other important factors include, among others:

•the impact of inflation on us and our members;

•our borrowing costs have and may continue to increase as a result of increases in interest rates;

•our expectations regarding our financial performance and future operating performance;

•our ability to attract and retain members, expand usage of our platform, sell subscriptions to our platform and convert individuals and organizations into paying customers;

•the timing and success of new features, integrations, capabilities and enhancements by us, or by competitors to their products, or any other changes in the competitive landscape of our market;

•the amount and timing of operating expenses and capital expenditures that we may incur to maintain and expand our business and operations to remain competitive;

•the sufficiency of our cash, cash equivalents and investments to meet our liquidity needs;

•our ability to make required payments under and to comply with the various requirements of our current and future indebtedness;

•our cash flows, the prevailing stock prices, general economic and market conditions and other considerations that could affect the specific timing, price and size of repurchases under our stock repurchase program or our ability to fund any stock repurchases;

•the war in Ukraine and escalating geopolitical tensions as a result of Russia's invasion of Ukraine;

•our ability to effectively manage our exposure to fluctuations in foreign currency exchange rates;

•the increased expenses associated with being a public company;

•the size of our addressable markets, market share and market trends;

•anticipated trends, developments and challenges in our industry, business and the highly competitive markets in which we operate;

•our expectations regarding our income tax liabilities and the adequacy of our reserves;

•our ability to effectively manage our growth and expand our infrastructure and maintain our corporate culture;

•our ability to identify, recruit and retain skilled personnel, including key members of senior management;

•the safety, affordability and convenience of our platform and our offerings;

Table of Contents

•our ability to successfully defend litigation brought against us;

•our ability to successfully identify, manage and integrate any existing and potential acquisitions of businesses, talent, technologies or intellectual property;

•general economic conditions in either domestic or international markets, including geopolitical uncertainty and instability;

•our protections against security breaches, technical difficulties, or interruptions to our platform;

•our ability to maintain, protect and enhance our intellectual property; and

•the other risks and uncertainties identified under Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022.

You should not rely upon forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this Quarterly Report on Form 10-Q primarily on our current expectations, estimates, forecasts and projections about future events and trends that we believe may affect our business, results of operations, financial condition and prospects. Although we believe that we have a reasonable basis for each forward-looking statement contained in this Quarterly Report on Form 10-Q, we cannot guarantee that the future results, levels of activity, performance, or events and circumstances reflected in the forward-looking statements will be achieved or occur at all. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties and other factors described in the section titled “Risk Factors” and elsewhere in our Annual Report on Form 10-K for the year ended December 31, 2022, and any subsequent filings, as well as those identified in this Quarterly Report on Form 10-Q. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Quarterly Report on Form 10-Q. The results, events and circumstances reflected in the forward-looking statements may not be achieved or occur, and actual results, events or circumstances could differ materially from those described in the forward-looking statements.

The forward-looking statements made in this Quarterly Report on Form 10-Q relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Quarterly Report on Form 10-Q to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments we may make.

In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this Quarterly Report on Form 10-Q, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and you are cautioned not to unduly rely upon these statements. Unless otherwise indicated or unless the context requires otherwise, all references in this document to “Expensify,” the “Company,” “we,” “us,” “our” or similar references are to Expensify, Inc. and its consolidated subsidiaries. Capitalized terms used and not defined above are defined elsewhere within this Quarterly Report on Form 10-Q.

iii

Part I - Financial Information

Item 1. Condensed Consolidated Financial Statements



1

Expensify, Inc.

Condensed Consolidated Balance Sheets

(unaudited, in thousands, except share data)



	As of June 30,		As of December 31,
	2023		2022
Assets
Cash and cash equivalents	$	97,795	$	103,787
Accounts receivable, net	14,922		16,448
Settlement assets, net	39,276		35,838
Prepaid expenses	5,050		8,825
Other current assets	24,606		22,217
Total current assets	181,649		187,115
Capitalized software, net	8,617		6,881
Property and equipment, net	14,545		14,492
Lease right-of-use assets	6,417		745
Deferred tax assets, net	409		344
Other assets	749		664
Total assets	$	212,386	$	210,241
Liabilities and stockholders' equity
Accounts payable	$	1,691	$	1,059
Accrued expenses and other liabilities	11,650		9,070
Borrowings under line of credit	15,000		15,000
Current portion of long-term debt, net of original issue discount and debt issuance costs	557		551
Lease liabilities, current	278		800
Settlement liabilities	32,500		33,882
Total current liabilities	61,676		60,362
Lease liabilities, non-current	6,226		—
Other liabilities	1,441		1,204
Long-term debt, net of original issue discount and debt issuance costs	43,180		51,434
Total liabilities	112,523		113,000
Commitments and contingencies (Note 4)
Stockholders' equity:
Preferred stock, par value $0.0001; 10,000,000 shares of preferred stock authorized as of June 30, 2023 and December 31, 2022; no shares of preferred stock issued and outstanding as of June 30, 2023 and December 31, 2022	—		—
Common stock, par value $0.0001; 1,000,000,000 shares of Class A common stock authorized as of June 30, 2023 and December 31, 2022; 68,347,794 and 68,238,245 shares of Class A common stock issued and outstanding as of June 30, 2023 and December 31, 2022, respectively; 24,996,238 and 24,997,561 shares of LT10 common stock authorized as of June 30, 2023 and December 31, 2022, respectively; 7,334,868 and 7,336,191 shares of LT10 common stock issued and outstanding as of June 30, 2023 and December 31, 2022, respectively; 24,999,020 shares of LT50 common stock authorized as of June 30, 2023 and December 31, 2022; 7,093,829 and 6,854,931 shares of LT50 common stock issued and outstanding as of June 30, 2023 and December 31, 2022, respectively	7		7
Additional paid-in capital	216,422		194,807
Accumulated deficit	(116,566)		(97,573)
Total stockholders' equity	99,863		97,241
Total liabilities and stockholders' equity	$	212,386	$	210,241


See accompanying notes to Condensed Consolidated Financial Statements.
2

Expensify, Inc.

Condensed Consolidated Statements of Operations

(unaudited, in thousands, except share and per share data)



	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Revenue	$	38,884	$	43,162	$	78,985	$	83,532
Cost of revenue, net	16,925		15,876		32,700		30,010
Gross margin	21,959		27,286		46,285		53,522
Operating expenses:
Research and development	5,094		3,584		10,512		7,285
General and administrative	11,712		15,432		24,141		29,438
Sales and marketing	14,714		12,244		23,897		25,616
Total operating expenses	31,520		31,260		58,550		62,339
Loss from operations	(9,561)		(3,974)		(12,265)		(8,817)
Interest and other expenses, net	(1,367)		(1,955)		(2,783)		(2,856)
Loss before income taxes	(10,928)		(5,929)		(15,048)		(11,673)
Provision for income taxes	(376)		(2,065)		(2,201)		(3,697)
Net loss	$	(11,304)	$	(7,994)	$	(17,249)	$	(15,370)
Net loss per share:
Basic and diluted	$	(0.14)	$	(0.10)	$	(0.21)	$	(0.19)
Weighted average shares of common stock used to compute net loss per share:
Basic and diluted	82,011,477		80,473,097		81,890,624		80,311,053


See accompanying notes to Condensed Consolidated Financial Statements.
3

Expensify, Inc.

Condensed Consolidated Statements of Changes in Stockholders’ Equity

(unaudited, in thousands, except share data)



	Preferred stock			Common stock			Additional paid-in capital		Accumulated deficit		Total stockholders' equity
	Shares	Amount		Shares	Amount
Three months ended June 30, 2023
Balance at March 31, 2023	—	$	—	82,806,528	$	7	$	206,207	$	(103,518)	$	102,696
Issuance of common stock on exercise of stock options	—	—		51,871	—		59		—		59
Vesting of early exercised stock options	—	—		—	—		186		—		186
Issuance of restricted stock units	—	—		3,760	—		30		—		30
Repurchases of early exercised stock options	—	—		(588)	—		(6)		—		(6)
Issuance of common stock under Matching Plan	—	—		278,425	—		977		—		977
Issuance of common stock in connection with restricted stock units vesting	—	—		261,840	—		—		—		—
Shares withheld from common stock issued to pay employee payroll taxes	—	—		(120,852)	—		(858)		—		(858)
Repurchase and retirement of common stock	—	—		(504,493)	—		(1,256)		(1,744)		(3,000)
Stock-based compensation	—	—		—	—		11,083		—		11,083
Net loss	—	—		—	—		—		(11,304)		(11,304)
Balance at June 30, 2023	—	$	—	82,776,491	$	7	$	216,422	$	(116,566)	$	99,863


See accompanying notes to Condensed Consolidated Financial Statements.
4

Expensify, Inc.

Condensed Consolidated Statements of Changes in Stockholders’ Equity

(unaudited, in thousands, except share data)



	Preferred stock			Common stock			Additional paid-in capital		Accumulated deficit		Total stockholders' equity
	Shares	Amount		Shares	Amount
Three months ended June 30, 2022
Balance at March 31, 2022	—	$	—	81,606,993	$	6	$	157,743	$	(73,282)	$	84,467
Issuance of common stock upon exercise of stock options	—	—		101,345	—		183		—		183
Vesting of early exercised stock options	—	—		—	—		456		—		456
Issuance of restricted stock units	—	—		3,896	—		28		—		28
Repurchases of early exercised stock options	—	—		(10,740)	—		(16)		—		(16)
Issuance of common stock under Matching Plan	—	—		71,522	—		1,188		—		1,188
Stock-based compensation	—	—		—	—		14,379		—		14,379
Net loss	—	—		—	—		—		(7,994)		(7,994)
Balance at June 30, 2022	—	$	—	81,773,016	$	6	$	173,961	$	(81,276)	$	92,691


See accompanying notes to Condensed Consolidated Financial Statements.
5

Expensify, Inc.

Condensed Consolidated Statements of Changes in Stockholders’ Equity

(unaudited, in thousands, except share data)



	Preferred stock			Common stock			Additional paid-in capital		Accumulated deficit		Total stockholders' equity
	Shares	Amount		Shares	Amount
Six months ended June 30, 2023
Balance at December 31, 2022	—	$	—	82,429,367	$	7	$	194,807	$	(97,573)	$	97,241
Issuance of common stock on exercise of stock options	—	—		102,865	—		125		—		125
Vesting of early exercised stock options	—	—		—	—		402		—		402
Issuance of restricted stock units	—	—		5,308	—		61		—		61
Repurchases of early exercised stock options	—	—		(1,323)	—		(13)		—		(13)
Issuance of common stock under Matching Plan	—	—		441,842	—		2,076		—		2,076
Issuance of common stock in connection with restricted stock units vesting	—	—		507,153	—		—		—		—
Shares withheld from common stock issued to pay employee payroll taxes	—	—		(204,228)	—		(1,524)		—		(1,524)
Repurchase and retirement of common stock	—	—		(504,493)	—		(1,256)		(1,744)		(3,000)
Stock-based compensation	—	—		—	—		21,744		—		21,744
Net loss	—	—		—	—		—		(17,249)		(17,249)
Balance at June 30, 2023	—	$	—	82,776,491	$	7	$	216,422	$	(116,566)	$	99,863


See accompanying notes to Condensed Consolidated Financial Statements.
6

Expensify, Inc.

Condensed Consolidated Statements of Changes in Stockholders’ Equity

(unaudited, in thousands, except share data)



	Preferred stock			Common stock			Additional paid-in capital		Accumulated deficit		Total stockholders' equity
	Shares	Amount		Shares	Amount
Six months ended June 30, 2022
Balance at December 31, 2021	—	$	—	81,400,860	$	6	$	142,515	$	(65,906)	$	76,615
Issuance of common stock upon exercise of stock options	—	—		307,075	—		435		—		435
Vesting of early exercised stock options	—	—		—	—		751		—		751
Issuance of restricted stock units	—	—		6,629	—		46		—		46
Repurchase of early exercised stock options	—	—		(13,070)	—		(20)		—		(20)
Issuance of common stock under Matching Plan	—	—		71,522	—		1,188		—		1,188
Stock-based compensation	—	—		—	—		29,046		—		29,046
Net loss	—	—		—	—		—		(15,370)		(15,370)
Balance at June 30, 2022	—	$	—	81,773,016	$	6	$	173,961	$	(81,276)	$	92,691


See accompanying notes to Condensed Consolidated Financial Statements.
7

Table of Contents

Expensify, Inc.

Condensed Consolidated Statements of Cash Flows

(unaudited, in thousands)



	Six Months Ended June 30,
	2023		2022
Cash flows from operating activities:
Net loss	$	(17,249)	$	(15,370)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	2,789		2,735
Reduction of operating lease right-of-use assets	334		358
Loss on impairment, receivables and sale or disposal of equipment	402		475
Stock-based compensation expense	20,345		28,428
Amortization of original issue discount and debt issuance costs	49		21
Deferred tax assets	(65)		(319)
Changes in assets and liabilities:
Accounts receivable, net	1,358		(906)
Settlement assets, net	(5,244)		(8,999)
Prepaid expenses	3,775		2,006
Related party loan receivable	—		14
Other current assets	(952)		1,193
Other assets	(88)		2
Accounts payable	632		(1,583)
Accrued expenses and other liabilities	2,670		(1,366)
Operating lease liabilities	(294)		(404)
Settlement liabilities	(1,382)		19,910
Other liabilities	128		963
Net cash provided by operating activities	7,208		27,158
Cash flows from investing activities:
Purchases of property and equipment	(479)		(267)
Software development costs	(2,043)		(468)
Net cash used in investing activities	(2,522)		(735)
Cash flows from financing activities:
Principal payments of finance leases	(404)		(394)
Principal payments of term loan	(8,300)		(297)
Repurchases of early exercised stock options	(13)		(20)
Proceeds from common stock purchased under Matching Plan	2,076		1,188
Proceeds from issuance of common stock on exercise of stock options	125		519
Payments for employee taxes withheld from stock-based awards	(1,524)		—
Repurchase and retirement of common stock	(3,000)		—
Net cash (used in) provided by financing activities	(11,040)		996
Net (decrease) increase in cash and cash equivalents and restricted cash	(6,354)		27,419
Cash and cash equivalents and restricted cash, beginning of period	147,710		125,315
Cash and cash equivalents and restricted cash, end of period	$	141,356	$	152,734
Supplemental disclosure of cash flow information:
Cash paid for interest	$	2,912	$	1,750
Cash paid for income taxes	$	2,251	$	606
Noncash investing and financing items:
Stock-based compensation capitalized as software development costs	$	1,399	$	618
Right-of-use assets acquired through operating leases	$	6,402	$	—
Accrued property and equipment	$	373	$	—
Reconciliation of cash and cash equivalents and restricted cash to the Condensed Consolidated Balance Sheets
Cash and cash equivalents	$	97,795	$	105,537
Restricted cash included in other current assets	20,986		16,077
Restricted cash included in settlement assets, net	22,575		31,120
Total cash, cash equivalents and restricted cash	$	141,356	$	152,734


See accompanying notes to Condensed Consolidated Financial Statements.
8

Table of Contents

Expensify, Inc.

Notes to the Condensed Consolidated Financial Statements

(unaudited)

NOTE 1 – GENERAL INFORMATION

Description of the Business

Expensify, Inc. ("Expensify") was incorporated in Delaware on April 29, 2009. Expensify offers a comprehensive expense management platform that integrates with a variety of third-party accounting applications, including QuickBooks Desktop, QuickBooks Online, Xero, NetSuite, Intacct, Sage, Microsoft Dynamics, MYOB and others. Expensify's product simplifies the way that employees and vendors manage and submit expense receipts and bills and provides efficiencies to companies for the payment of those bills. Expensify delivers its services over the internet to corporations and individuals under license arrangements and offers unique pricing options for small and midsized businesses and enterprises on a per-active-member basis.

Expensify also offers an Expensify charge card (the "Expensify Card"), which is primarily distributed to corporate customers in the United States ("U.S.") that subsequently distribute the card to their employees for business use. The Expensify Card allows customers to have real-time control over their employees' spending and compliance with spending limits in addition to eReceipt reporting on purchases.

Basis of Presentation and Principles of Consolidation

The accompanying condensed consolidated financial statements include the accounts of Expensify and its wholly-owned subsidiaries (the "Company") and have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") and the applicable rules and regulations of the Securities and Exchange Commission ("SEC") for interim reporting in conformity with the instructions to Form 10-Q and Article 10 of Regulation S-X. Certain information and footnote disclosures normally included in financial statements presented in accordance with GAAP have been condensed or omitted pursuant to such SEC rules. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report on Form 10-K for the year ended December 31, 2022 ("2022 Annual Report").

All intercompany transactions and balances have been eliminated in consolidation. In the opinion of management, the accompanying condensed consolidated financial statements reflect all normal and recurring adjustments that are necessary for the fair presentation of the Company's financial position, results of operations, equity, and cash flows for the periods presented.

Results of operations for the three and six months ended June 30, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023 or for any other future annual or interim period.

Use of Estimates

The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates and judgments are based on historical experience, forecasted events and various other assumptions that the Company believes to be reasonable under the circumstances. Estimates and judgments are evaluated on an ongoing basis. Actual results could differ from those estimates. Changes in estimates are recorded in the period in which they become known.

Significant estimates and assumptions by management affect the Company’s classification of employee and employee-related expenses, the useful lives and recoverability of long-lived assets, income taxes, capitalization of internal-use software costs, stock-based compensation and the Company's incremental borrowing rate (IBR) utilized to measure its operating lease assets and lease liabilities.


9

Table of Contents

Expensify, Inc.

Notes to the Condensed Consolidated Financial Statements

(unaudited)

Updates to Significant Accounting Policies

The Company’s significant accounting policies are discussed in Note 2 of the 2022 Annual Report. Since the date the 2022 Annual Report was filed with the SEC, there have been no material changes to the Company's significant accounting policies, including the status of recent accounting pronouncements adopted, other than those detailed below.

Recently Adopted Accounting Pronouncements

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments, with subsequent ASUs issued that clarify the guidance (collectively, "Topic 326"). Topic 326 requires an entity to utilize a new impairment model known as the current expected credit loss ("CECL") model to estimate its “lifetime expected credit losses" using a forward-looking approach and to record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The CECL model is expected to result in more timely recognition of credit losses. Topic 326 also requires new disclosures for financial assets measured at amortized cost, loans and available-for-sale debt securities.

As a result of no longer qualifying as an emerging growth company as of December 31, 2022, the Company was required to adopt Topic 326 retroactive to January 1, 2022. The Company was not required to amend quarterly filings issued subsequent to January 1, 2022 in which the Company filed under the legacy credit loss guidance of Accounting Standards Codification ("ASC") Topic 310. As such, the 2022 Annual Report was the first period under which the Company reported credit loss estimates in accordance with Topic 326. The adoption of Topic 326 did not have a material impact on the Company's financial position or results of operations as of and for the three and six months ended June 30, 2022.

NOTE 2 - REVENUE AND CERTAIN STATEMENT OF OPERATIONS COMPONENTS

Revenue by geographic region, based on user address, was as follows (in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
United States	$	35,487	$	39,388	$	72,122	$	75,906
All other locations	3,397		3,774		6,863		7,626
Total revenue	$	38,884	$	43,162	$	78,985	$	83,532

No individual customer represented more than 10% of the Company’s total revenue during the three and six months ended June 30, 2023 and 2022.

Cashback Rewards

The Company offers a cashback rewards program to all Expensify Card customers based on volume of Expensify Card transactions and Software as a Service ("SaaS") subscription tier. Cashback rewards are earned on a monthly basis and paid out the following month. The Company considers the cashback payments to customers as consideration payable to a customer and it is recorded as contra revenue within Revenue on the Condensed Consolidated Statements of Operations. Cashback rewards for the three months ended June 30, 2023 and 2022 was $1.8 million and $0.7 million, respectively. Cashback rewards for the six months ended June 30, 2023 and 2022 was $3.0 million and $1.2 million, respectively.


10

Table of Contents

Expensify, Inc.

Notes to the Condensed Consolidated Financial Statements

(unaudited)

Consideration From a Vendor, Net

The Company receives consideration from a vendor for monetizing Expensify Card activities. This consideration, net of credit card processing fees paid to the vendor, is included as a reduction to Cost of revenue, net within the Condensed Consolidated Statements of Operations. Consideration from a vendor, net for the three months ended June 30, 2023 and 2022 was $2.4 million and $1.5 million, respectively. Consideration from a vendor, net for the six months ended June 30, 2023 and 2022 was $4.5 million and $2.7 million, respectively.

NOTE 3 - CERTAIN BALANCE SHEET COMPONENTS

Other Current Assets

Other current assets consisted of the following (in thousands):


	As of June 30,		As of December 31,
	2023		2022
Expensify Card posted collateral for funds held for customers	$	9,024	$	11,509
Cash in transit for funds held for customers	6,088		2,361
Expensify.org restricted cash	5,721		5,518
Income tax receivable	3,325		2,471
Expensify Payments LLC restricted cash	99		102
Matching Plan escrow and other restricted cash	54		52
Deferred contract acquisition costs	53		—
Other	242		204
Other current assets	$	24,606	$	22,217

Capitalized Software, Net

Capitalized software, net consisted of the following (in thousands):


	As of June 30,		As of December 31,
	2023		2022
Capitalized software development costs	$	17,139	$	14,052
Less: accumulated amortization	(8,522)		(7,171)
Capitalized software, net	$	8,617	$	6,881

Amortization expense related to capitalized software development costs is recorded in Cost of revenue, net on the Condensed Consolidated Statements of Operations. Amortization expense was $0.8 million and $0.7 million for the three months ended June 30, 2023 and 2022, respectively. Amortization expense was $1.5 million and $1.3 million for the six months ended June 30, 2023 and 2022, respectively.


11

Table of Contents

Expensify, Inc.

Notes to the Condensed Consolidated Financial Statements

(unaudited)

Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):


	As of June 30,		As of December 31,
	2023		2022
Computers and equipment	$	178	$	178
Furniture and fixtures	1,855		1,698
Leasehold improvements	6,957		6,948
Commercial building	6,493		6,493
Land	4,151		4,151
Construction in progress	3,339		2,551
Total property and equipment	22,973		22,019
Less: accumulated depreciation	(8,428)		(7,527)
Property and equipment, net	$	14,545	$	14,492

Depreciation expense related to property and equipment is recorded in General and administrative and Sales and marketing on the Condensed Consolidated Statements of Operations. Depreciation expense related to property and equipment for the three months ended June 30, 2023 and 2022 was $0.4 million and $0.5 million, respectively. Depreciation expense related to property and equipment for the six months ended June 30, 2023 and 2022 was $0.9 million and $1.0 million, respectively.

Accrued Expenses and Other Liabilities

Accrued expenses and other liabilities consisted of the following (in thousands):


	As of June 30,		As of December 31,
	2023		2022
Sales, payroll and other taxes payable	$	3,254	$	2,721
Professional fees	2,704		1,473
Partner payouts and advertising fees	1,444		669
Interest payable	1,389		1,318
Restricted common stock liability for early stock option exercises	881		1,283
Cashback rewards	524		223
Matching Plan payroll liability	183		195
Accrued expense reports	168		291
Commissions payable	135		—
Hosting and license fees	85		75
Credit card processing fees	41		22
Other	842		800
Accrued expenses and other liabilities	$	11,650	$	9,070


12

Table of Contents

Expensify, Inc.

Notes to the Condensed Consolidated Financial Statements

(unaudited)

NOTE 4 - COMMITMENTS AND CONTINGENCIES

Finance and Operating Lease Arrangements

During the six months ended June 30, 2023, the Company entered into four operating lease agreements. The components of lease cost reflected in the Condensed Consolidated Statements of Operations for all leases were as follows (in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Finance lease cost:
Amortization of ROU assets	$	197	$	198	$	395	$	395
Interest on lease liabilities	1		6		4		14
Total finance lease cost	198		204		399		409
Operating lease cost	244		173		430		358
Total lease cost	$	442	$	377	$	829	$	767

Other information related to leases was as follows (in thousands, except as noted within):


	As of June 30,			As of December 31,
	2023			2022
Finance lease ROU asset (included within Lease right-of-use assets)	$	66		$	461
Operating lease ROU asset (included within Lease right-of-use assets)	$	6,351		$	284
Weighted average remaining lease term (in years):
Finance leases	0.08			0.58
Operating leases	9.61			0.42
Weighted average discount rate:
Finance leases	2.50		%	2.50		%
Operating leases	8.30		%	5.30		%

Supplemental cash flow information related to leases was as follows (in thousands):


	Six months ended June 30,
	2023		2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	(322)	$	(399)
Operating cash flows from finance leases	$	(4)	$	(14)
Financing cash flows from finance leases	$	(404)	$	(394)


13

Table of Contents

Expensify, Inc.

Notes to the Condensed Consolidated Financial Statements

(unaudited)

Maturities of lease liabilities as of June 30, 2023 were as follows (in thousands):


For the year ending:	Finance leases		Operating leases
Remainder of 2023	$	68	$	176
2024	—		838
2025	—		1,079
2026	—		1,018
2027	—		1,033
Thereafter	—		5,562
Total future lease payments	68		9,706
Less: imputed interest	—		(3,270)
Less: Lease liabilities, current	(68)		(210)
Lease liabilities, non-current	$	—	$	6,226

Amortizing Term Mortgage

In August 2019, the Company entered into an $8.3 million amortizing term mortgage agreement with Canadian Imperial Bank of Commerce ("CIBC") for the Company's commercial building located in Portland, Oregon. The agreement requires principal and interest payments due each month over a 30 year period. Interest accrues at a fixed rate of 5.00% per year until August 2024, at which point the interest rate changes to the Wall Street Journal Prime Rate less 0.25% for the remaining term of the mortgage. The borrowings are secured by the building. The outstanding balance of the amortizing term mortgage was $7.8 million as of June 30, 2023 and December 31, 2022.

2021 Amended Term Loan

In September 2021, the Company amended and restated its loan and security agreement with CIBC ("2021 Amended Term Loan") to refinance the existing non-amortizing and amortizing term loans, establish a single term loan of up to $75.0 million, consisting of a $45.0 million initial term loan effective immediately with an option to enter into an additional $30.0 million delayed term loan, and increase the monthly revolving line of credit to $25.0 million. The option for the delayed term loan expired in March 2023. The term loan and revolving line of credit mature in September 2026 and September 2024, respectively. Approximately $23.5 million of the loan proceeds were used to immediately repay the remaining balances under the amortizing and non-amortizing term loans at the time of the amendment, as well as commitment fees and other debt issuance costs associated with the amendment. The remaining proceeds from the initial term loan were utilized to fund the Company's normal business operations.

Under the 2021 Amended Term Loan, the initial term loan of $45.0 million is payable over a 60 month period with principal and accrued interest payments due each quarter, commencing on September 30, 2021. The 2021 Amended Term Loan amortizes in equal quarterly installments of $0.1 million through September 30, 2024, $0.2 million beginning October 1, 2024 and $0.6 million beginning October 1, 2025, with any remaining principal balance due and payable on maturity. The amounts borrowed bear interest at the bank’s reference rate plus 2.25% (10.50% as of June 30, 2023) beginning on September 30, 2021 and continuing on a quarterly basis through maturity of the term loan. The borrowings are secured by substantially all the Company’s assets. As of June 30, 2023 and December 31, 2022, the outstanding balance of the 2021 Amended Term Loan was $36.2 million and $44.5 million, respectively.


14

Table of Contents

Expensify, Inc.

Notes to the Condensed Consolidated Financial Statements

(unaudited)

During the three months ended June 30, 2023, the Company made a prepayment of $8.0 million for the 2021 Amended Term Loan. As a result of this prepayment, the Company recorded an immaterial amount of loss on extinguishment within Interest and other expenses, net.

Monthly Revolving Line of Credit

The line of credit agreement, as amended with the 2021 Amended Term Loan, provides borrowings up to $25.0 million. Borrowings under the line of credit bear interest at CIBC’s reference rate plus 1.00% (9.25% as of June 30, 2023) and are secured by substantially all of the Company’s assets. As of June 30, 2023 and December 31, 2022, there were $15.0 million of borrowings under the line of credit and $10.0 million of capacity available for additional borrowings.

In connection with the amortizing term mortgage and the 2021 Amended Term Loan, the Company recorded an immaterial amount of debt issuance costs and the 2021 Amended Term Loan was subject to an original issue discount. These amounts are being amortized to interest expense over the term of the respective agreements using the effective interest method. As of June 30, 2023 and December 31, 2022, unamortized original issue discount and debt issuance costs were $0.2 million and $0.3 million, respectively.

Future aggregate annual principal payments on long-term debt as of June 30, 2023 is expected to be as follows (in thousands):


For the year ending:
Remainder of 2023	$	297
2024	715
2025	1,398
2026	34,356
2027	176
Thereafter	7,014
Total principal payments	43,956
Less: unamortized original issue discount and debt issuance costs	(219)
Less: Current portion of long-term debt, net of unamortized original issue discount and debt issuance costs	(557)
Long-term debt, net of unamortized original issue discount and debt issuance costs	$	43,180

As of June 30, 2023, the Company was not in compliance with all debt covenants, specifically the covenant restricting the amount of repurchases of common stock, which includes RSU net share settlements, and the covenant related to the requirement to maintain all deposit, operating and collateral accounts with CIBC with certain exceptions during the period. A waiver was obtained from CIBC. The Company does not believe non-compliance with these covenants had any material impact on the Company or its operations.


15

Table of Contents

Expensify, Inc.

Notes to the Condensed Consolidated Financial Statements

(unaudited)

Defined Contribution Plans

The Company sponsors a U.S. 401(k) defined contribution plan for all eligible employees who elect to participate. The Company is permitted to make discretionary profit sharing and 401(k) matching contributions as defined in the plan and as approved by the Board of Directors. Effective January 1, 2018, the Company matches up to 4.50% of each participant’s eligible compensation. The Company’s actual contribution may be reduced by certain available forfeitures, if any, during the plan year. No discretionary profit-sharing contributions were made during the three and six months ended June 30, 2023 and 2022. The Company’s 401(k) matching contributions for the three months ended June 30, 2023 and 2022 were $0.2 million. The Company’s 401(k) matching contributions for the six months ended June 30, 2023 and 2022 were $0.5 million and $0.4 million, respectively.

Legal

From time to time in the normal course of business, the Company may be involved in claims, proceedings and litigation. In the case of any litigation, the Company records a provision for a liability when management believes that it is both probable that a liability has been incurred, and the amount of the loss can be reasonably estimated. The Company reviews such provisions at least quarterly and adjusts such provisions to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a particular case.

As of June 30, 2023, there were no legal contingency matters, either individually or in aggregate, that would have a material adverse effect on the Company’s financial position, results of operations or cash flows.

NOTE 5 - STOCK INCENTIVE PLANS

2009 and 2019 Stock Plans

In 2009, the Board of Directors approved the 2009 Stock Plan ("2009 Stock Plan"). As amended in 2015, the 2009 Stock Plan permitted the Company to grant up to 16,495,150 shares of common stock. In January 2018, the Company increased the number of shares of common stock reserved under the 2009 Stock Plan by 535,130 shares, from 16,495,150 shares to 17,030,280 shares. In April 2019, the Board of Directors approved the adoption of the 2019 Stock Plan ("2019 Stock Plan", and together with the 2009 Stock Plan, "Stock Plans"). The 2019 Stock Plan permitted the Company to grant up to 8,173,970 additional shares, increasing the overall common stock reserved for grant under the Stock Plans to 25,204,250 shares. In September 2021, the Board of Directors approved the grant of 8,679,380 restricted stock units under the 2019 Stock Plan, covering an aggregate of 4,339,690 shares of each of Class A and LT50 common stock effective immediately prior to the effectiveness of the Company's IPO Registration Statement on Form S-1 ("IPO Registration Statement") on November 9, 2021. On November 9, 2021, the Board of Directors amended and restated the 2019 Stock Plan to, among other things, increase the common stock reserved for issuance under the 2019 Stock Plan to an aggregate of 16,856,770 shares of Class A and LT50 common stock.

Following the completion of the initial public offering of the Company’s Class A common stock ("IPO"), the Company did not and does not intend to make any further grants under the Stock Plans. However, the Stock Plans will continue to govern the terms and conditions of the outstanding awards granted under the Stock Plans. Upon the expiration, forfeiture, cancellation, withholding of shares upon exercise or settlement of an award to satisfy the exercise price or tax withholding, or repurchase of any shares of Class A common stock underlying outstanding stock-based awards granted under the 2009 Stock Plan or of Class A or LT50 common stock underlying outstanding stock-based awards granted under the 2019 Stock Plan, an equal number of shares of Class A common stock will become available for grant under the 2021 Incentive Award Plan ("2021 Plan") and the Company's 2021 Stock Purchase and Matching Plan ("Matching Plan" and together with the 2021 Plan, "2021 Incentive Plans").


16

Table of Contents

Expensify, Inc.

Notes to the Condensed Consolidated Financial Statements

(unaudited)

2021 Incentive Plans

In November 2021, the Board of Directors adopted, and its stockholders approved, the 2021 Incentive Plans, which both became effective immediately before the effectiveness of the IPO Registration Statement and use a combined share reserve. Under the 2021 Incentive Plans, 11,676,932 shares of Class A common stock were initially reserved for issuance pursuant to a variety of stock-based awards, including incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock awards, restricted stock units ("RSUs"), and other forms of equity and cash compensation under the 2021 Plan and purchase rights and matching awards under the Matching Plan. The number of shares initially reserved for issuance or transfer pursuant to awards under the 2021 Incentive Plans will be increased upon the expiration, forfeiture, cancellation, withholding of shares upon exercise or settlement of an award to satisfy the exercise price or tax withholding, or repurchase of any shares of Class A common stock underlying outstanding stock-based awards granted under the 2009 Stock Plan or of Class A or LT50 common stock underlying outstanding stock-based awards granted under the 2019 Stock Plan. The number of shares of Class A common stock reserved for issuance under the 2021 Incentive Plans as of June 30, 2023 and December 31, 2022 was 22,282,735 shares and 17,336,973 shares, respectively. The number of shares will automatically increase each subsequent January 1 through January 1, 2031, by the lesser of (A) 6% of the aggregate number of shares of all classes of common stock outstanding on the immediately preceding calendar year, or (B) such lesser number of shares as determined by the Company’s board of directors or compensation committee; provided, however, that no more than 87,576,990 shares of Class A common stock may be issued upon the exercise of incentive stock options.

Matching Plan

The Matching Plan operates using consecutive three month offering periods that commenced on March 15, 2022. Employees, consultants and directors (collectively, "Service Providers") of the Company can participate in the Matching Plan by electing to contribute compensation through payroll deductions or from fee payments or may be granted discretionary awards under the Matching Plan. On the last day of the offering period the contributions made during the offering period are used to purchase shares of Class A common stock.

The price at which Class A common stock is purchased under the Matching Plan equals the average of the high and low trading price of a share of Class A common stock as of the last trading day of the offering period. At the end of each offering period, the Company may provide a discretionary match up to 1/10 of a share of Class A common stock for each share of Class A common stock purchased by or issued to a service provider under the Matching Plan that is retained through the end of the applicable offering period. No fractional shares will be issued by the Company. The Company will round to the nearest full share for shares purchased by a service provider as well as any matched shares issued to a service provider under the Matching Plan. The match rate applicable to each offering period shall be limited to 1.50% of the shares of any class of capital stock outstanding as of the exercise date applicable to such offering period. The Company estimates the fair value of matched shares provided under the Matching Plan using the Black-Scholes option-pricing model on the date of grant. The Company recognizes stock-based compensation expense related to the matched shares pursuant to its Matching Plan on a straight-line basis over the applicable three month offering period.

Service Providers who participated in the Matching Plan for the offering period ended June 14, 2023 purchased a total of 140,158 Class A common shares, based on a purchase price of $6.97, resulting in gross cash proceeds to the Company of $1.0 million.

Service Providers who participated in the Matching Plan for the offering period ended June 14, 2022 purchased a total of 67,946 Class A common shares, based on a purchase price of $17.42, resulting in gross cash proceeds to the Company of $1.2 million.


17

Table of Contents

Expensify, Inc.

Notes to the Condensed Consolidated Financial Statements

(unaudited)

For the offering period ended June 14, 2023, the Company elected to match each share of Class A common stock purchased by or issued under the Matching Plan with 1/20 of a share of Class A common stock. During the three and six months ended June 30, 2023, the Company granted a total of 20,748 and 36,846 shares, respectively, of Class A common stock as a matching contribution under the Matching Plan, net of a total of 6,817 shares withheld for taxes during the three months ended June 30, 2023.

For the offering period ended June 14, 2022, the Company elected to match each share of Class A common stock purchased by or issued under the Matching Plan with 1/20 of a share of Class A common stock. During the three and six months ended June 14, 2022, the Company granted a total of 3,576 shares of Class A common stock as a matching contribution under the Matching Plan.

In June 2023, the Company made a discretionary contribution under the Matching Plan to eligible Service Providers. During the three and six months ended June 30, 2023, the Company granted a total of 75,311 shares of Class A common stock as a discretionary contribution under the Matching Plan, net of a total of 35,391 shares withheld for taxes.

Restricted Stock Units

On September 24, 2021, under the 2019 Stock Plan, the Company approved the grant of Class A and LT50 common stock RSUs to Service Providers effective November 9, 2021, the date the Company amended its Certificate of Incorporation, to include, among other things, LT50 common stock. RSUs granted to Service Providers on November 9, 2021 that were approved in September 2021 vest upon the satisfaction of both a performance and service condition. The performance condition was satisfied immediately prior to the effectiveness of the IPO Registration Statement. The service condition is satisfied over eight years with 1/8 of the grant vesting on September 15, 2022 and quarterly vesting of 1/32 of the grant every December 15, March 15, June 15 and September 15 (each, a "Specified Quarterly Date") thereafter until fully vested, in each case subject to continued service to the Company. All RSUs granted to Service Providers after the IPO, under the 2021 Plan, have a service condition only, which is satisfied over eight years from the vesting commencement date corresponding to one of the Specified Quarterly Dates nearest the date of grant, with 1/8 of each grant vesting on the first anniversary of the vesting commencement date and 1/32 of each grant vesting in equal quarterly installments thereafter until fully vested, in each case, subject to continued service to the Company.

Pursuant to the Company's Non-Employee Director Compensation Program, which was adopted under the 2021 Incentive Plans, the Company granted 55,731 Class A common stock RSUs for the six months ended June 30, 2023. A total of 24,792 Class A common RSUs vested during the six months ended June 30, 2023 related to previously granted RSU awards as the quarterly service conditions were satisfied.

During the six months ended June 30, 2023, RSU activity for Service Providers and non-employee directors was as follows:


	Class A Common Stock	LT50 Common Stock	Weighted average grant date fair value per share
Outstanding at December 31, 2022	3,379,657	3,304,643	$	33.88
RSUs granted	55,731	—	$	8.17
RSUs vested	(266,381)	(238,898)	$	32.65
RSUs cancelled/forfeited/expired	(100,709)	(100,709)	$	40.92
Outstanding at June 30, 2023	3,068,298	2,965,036	$	33.71


18

Table of Contents

Expensify, Inc.

Notes to the Condensed Consolidated Financial Statements

(unaudited)

As of June 30, 2023, there was $177.8 million of unamortized stock-based compensation cost related to unvested RSUs, which is expected to be recognized over the remaining weighted average life of 5.80 years. As of December 31, 2022, there was $204.2 million of unamortized stock-based compensation cost related to unvested RSUs, which was expected to be recognized over the remaining weighted average life of 6.23 years.

Stock Options

The Stock Plans and the 2021 Plan provide for the grant of incentive and nonstatutory stock options to employees, non-employee directors and consultants of the Company. Under the Stock Plans and the 2021 Plan, the exercise price of incentive stock options must be equal to at least 110% of the fair market value of the common stock on the grant date for a “ten-percent holder” or 100% of the fair market value of the common stock on the grant date for any other participant. The exercise price of nonstatutory options granted must be equal to at least 100% of the fair market value of the Company’s common stock on the date of grant.

The Company has only granted options under the Stock Plans. Options typically vest over four years and are exercisable at any time after the grant date, provided that Service Providers exercising unvested options receive restricted common stock that is subject to repurchase at the original exercise price upon termination of service. The repurchase right lapses in accordance with the vesting schedule of the exercised option. Early exercises of options prior to vesting are not deemed to be substantive exercises for accounting purposes and accordingly, amounts received for early exercises of unvested options are recorded as a liability. These repurchase terms are considered to be a forfeiture provision and do not result in variable accounting. There was an immaterial amount of exercised restricted common stock repurchased during the six months ended June 30, 2023 and 2022.

As of June 30, 2023 and December 31, 2022, there were 584,037 and 813,311 shares subject to repurchase, respectively, related to unvested stock options that had been early exercised. As of June 30, 2023 and December 31, 2022, the Company recorded a liability related to shares subject to repurchase of $0.9 million and $1.3 million, respectively, which is included within Accrued expenses and other liabilities in the accompanying Condensed Consolidated Balance Sheets. These amounts are reclassified to Common stock and Additional paid-in capital as the underlying shares vest.

A summary of the Company's stock option activity was as follows:


	Shares	Weighted average exercise price per share		Weighted average remaining contractual life (in years)
Outstanding at December 31, 2022	6,301,650	$	1.67	5.20
Options exercised	(102,865)	$	1.21
Options cancelled/forfeited/expired	(44,789)	$	3.40
Outstanding at June 30, 2023	6,153,996	$	1.66	4.63
Exercisable at June 30, 2023	6,024,296	$	1.46	4.59

The total pretax intrinsic value of options exercised during the six months ended June 30, 2023 and 2022 was $0.7 million and $7.8 million, respectively. The total pretax intrinsic value of options outstanding at June 30, 2023 and December 31, 2022 was $39.9 million and $46.0 million, respectively. The intrinsic value is the difference between the estimated fair market value of the Company’s common stock at the date of exercise and the exercise price for in-the-money options.


19

Table of Contents

Expensify, Inc.

Notes to the Condensed Consolidated Financial Statements

(unaudited)

As of June 30, 2023, there was $6.0 million of unrecognized stock-based compensation cost related to unvested stock options, which is expected to be recognized over a weighted average period of 0.98 years. As of December 31, 2022, there was $8.1 million of unrecognized stock-based compensation cost related to unvested stock options, which was expected to be recognized over a weighted average period of 1.21 years.

Cash received from option exercises and purchases of shares under the Stock Plans for the six months ended June 30, 2023 and 2022 was $0.1 million and $0.5 million, respectively.

Stock-Based Compensation

The following table summarizes the stock-based compensation recognized for options granted under the 2009 Stock Plan, options and RSUs granted under the 2019 Stock Plan, RSUs granted under the 2021 Plan and matching and discretionary shares issued under the Matching Plan (in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Matching Plan shares	$	1,072	$	15	$	1,321	$	17
Stock options	874		993		1,774		1,999
Restricted stock units	9,137		13,040		18,649		26,412
Stock-based compensation	$	11,083	$	14,048	$	21,744	$	28,428

Stock-based compensation expense is allocated based on the cost center to which the award holder spent time during the reported periods. Stock-based compensation expense is included in the following components of expenses on the accompanying Condensed Consolidated Statements of Operations (in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Cost of revenue, net	$	3,600	$	4,704	$	6,906	$	9,611
Research and development	2,455		1,877		4,661		4,298
General and administrative	2,376		5,463		5,020		10,439
Sales and marketing	1,910		2,004		3,758		4,080
Stock-based compensation expense	$	10,341	$	14,048	$	20,345	$	28,428

Stock-based compensation capitalized as internally developed software costs was $0.7 million and $0.3 million for the three months ended June 30, 2023 and 2022, respectively. Stock-based compensation capitalized as internally developed software costs was $1.4 million and $0.6 million for the six months ended June 30, 2023 and 2022, respectively.

NOTE 6 - INCOME TAXES

For the three and six months ended June 30, 2023, the Company prepared its interim tax provision by applying a year-to-date effective tax rate, which the Company believes results in the best estimate of the annual effective tax rate.

For the three months ended June 30, 2023 and 2022, the Company recorded a provision for income taxes of $0.4 million and $2.1 million, respectively, which resulted in effective tax rates of (3.4)% and (34.8)%, respectively.


20

Table of Contents

Expensify, Inc.

Notes to the Condensed Consolidated Financial Statements

(unaudited)

For the six months ended June 30, 2023 and 2022, the Company recorded a provision for income taxes of $2.2 million and $3.7 million, respectively, which resulted in effective tax rates of (14.6)% and (31.7)%, respectively.

The principal reasons for the difference between the statutory rate and the effective rate for 2023 were primarily due to non-deductible stock-based compensation, Section 162(m) of the Internal Revenue Code ("IRC") compensation limitations, and the change in the valuation allowance. The principal reasons for the difference between the statutory rate and the effective rate for 2022 was due to the change in valuation allowance.

The Company follows the provisions of ASC 740-10, Accounting for Uncertainty in Income Taxes. ASC 740-10 prescribes a comprehensive model for the recognition, measurement, presentation and disclosure in financial statements of uncertain tax positions that have been taken or expected to be taken on a tax return. As of June 30, 2023 and December 31, 2022, the Company recorded an uncertain tax position liability, inclusive of interest and penalties, of $1.3 million and $1.2 million respectively, within Other liabilities on the Condensed Consolidated Balance Sheets. This liability includes an immaterial amount of interest and penalties as of June 30, 2023 and no interest and penalties as of December 31, 2022.

NOTE 7 - NET LOSS PER SHARE

The following table sets forth the computation of basic and diluted net loss per share (in thousands, except share and per share data):


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Numerator
Net loss, basic and diluted	$	(11,304)	$	(7,994)	$	(17,249)	$	(15,370)
Denominator
Weighted average shares of common stock used to compute net loss per share, basic and diluted	82,011,477		80,473,097		81,890,624		80,311,053
Net loss per share, basic and diluted	$	(0.14)	$	(0.10)	$	(0.21)	$	(0.19)

The rights, including the liquidation and dividend rights, of the holders of Class A, LT10 and LT50 common stock are identical, except with respect to voting, conversion and transfer rights. Each share of Class A common stock is entitled to one vote per share, each share of LT10 common stock is entitled to 10 votes per share and each share of LT50 common stock is entitled to 50 votes per share. Each share of LT10 and LT50 common stock is convertible into one share of Class A common stock voluntarily at the option of the holder after the satisfaction of certain requirements, which includes a 10-month notice period for LT10 common stock and a 50-month notice period for LT50 common stock to convert to Class A common stock, or automatically upon certain events. The Class A common stock has no conversion rights. As the liquidation and dividend rights are identical for Class A, LT10 and LT50 common stock, the undistributed earnings are allocated on a proportional basis based on the number of weighted average shares within each class of common stock during the period and the resulting net loss per share attributable to common stockholders will be the same for the Class A, LT10 and LT50 common stock on an individual or combined basis.


21

Table of Contents

Expensify, Inc.

Notes to the Condensed Consolidated Financial Statements

(unaudited)

The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive:


	Three Months Ended June 30,		Six Months Ended June 30,
	2023	2022	2023	2022
Weighted-average stock options	4,061,602	5,418,741	4,213,114	6,065,482
Matching shares	247	6,220	352	6,748
Total	4,061,849	5,424,961	4,213,466	6,072,230

NOTE 8 - EQUITY

On May 10, 2022, the Executive Committee of the Board of Directors approved a share repurchase program with authorization to purchase up to $50.0 million of shares of Class A common stock ("2022 Share Repurchase Program"). The Company may repurchase shares from time to time through open market purchases, in privately negotiated transactions or by other means, including the use of trading plans intended to qualify under Rule 10b5-1 of the Securities Exchange Act of 1934 ("Exchange Act"), in accordance with applicable securities laws and other restrictions. The actual timing, manner, price and total amount of future repurchases will depend on a variety of factors, including business, economic and market conditions, corporate and regulatory requirements, prevailing stock prices, restrictions under the terms of loan agreements and other considerations. The 2022 Share Repurchase Program does not obligate the Company to acquire any particular amount of Class A common stock, and the program may be suspended or terminated at any time by the Company at its discretion without prior notice.

During the three and six months ended June 30, 2023, the Company repurchased 504,493 shares of Class A common stock under the 2022 Share Repurchase Program, at a total cost to the Company of $3.0 million.

NOTE 9 - RELATED PARTY TRANSACTIONS

During the six months ended June 30, 2023 and 2022, Expensify, Inc. contributed $0.2 million and $1.9 million, respectively, to its wholly-owned subsidiary, Expensify.org, a nonprofit benefit organization established by the Company. There was an immaterial amount of commitments from Expensify, Inc. that remained open for contribution as of June 30, 2023 and December 31, 2022.

There are no other significant related party transactions for the Company as of June 30, 2023, except as noted elsewhere in these condensed consolidated financial statements.


22

Table of Contents

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q and with our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2022 ("2022 Annual Report"). This discussion contains forward-looking statements based upon current plans, expectations and beliefs involving risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under Part I, Item 1A. "Risk Factors" in our 2022 Annual Report and included elsewhere in this Quarterly Report on Form 10-Q. See "Special Note Regarding Forward-Looking Statements."

OVERVIEW

Expensify is a cloud-based expense management software platform that helps the smallest to the largest businesses simplify the way they manage money. Every day, people from all walks of life in organizations around the world use Expensify to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. Since our founding in 2008, we have added over 12 million members to our community and processed and automated 1.5 billion expense transactions on our platform as of June 30, 2023, freeing people to spend less time managing expenses and more time doing the things they love. For the quarter ended June 30, 2023, an average of 742,000 paid members across 45,300 companies and over 200 countries and territories used Expensify to make money easy.

Components of Results of Operations

Revenue

We generate revenue from subscription fees based on the usage of our cloud-based expense management software platform under arrangements paid monthly in arrears that are either (i) month-to-month and can be terminated by either party without penalty at any time or (ii) annual arrangements based on a minimum number of monthly members. Annual subscription customers who wish to terminate their contracts before the end of the term are required to pay the remaining obligation in full plus any fees or penalties set forth in the agreement. We charge our customers subscription fees for access to our platform based on the number of monthly active members and level of service. The contractual price is based on either negotiated fees or rates published on our website. We generate most of our revenue from customers who have a credit card or debit card on file with us that is automatically charged each month. Virtually all of our customers have a standard terms of service contract, with the few exceptions on bespoke service contracts.

Our contracts with our customers include two performance obligations: access to the hosted software service, inclusive of all features available within the platform, and the related customer support. We account for the platform access and the support as a combined performance obligation because they have the same pattern of transfer over the same period and are therefore delivered concurrently. We satisfy our performance obligation over time each month as we provide platform access and support services to customers and as such recognize revenue over time. We recognize revenue net of applicable taxes imposed on the related transaction.


23

Table of Contents

We offer a cashback rewards program to all customers based on volume of Expensify Card transactions and software as a service ("SaaS") subscription tier. Cashback rewards are earned on a monthly basis and are paid out the following month. We consider our cashback payments to customers as consideration payable to a customer, and the payments are recorded as contra revenue within Revenue on the Condensed Consolidated Statements of Operations. We also record a cashback rewards liability that represents the consideration payable to customers for earned cashback rewards. The cashback rewards fluctuate over time as customers meet eligibility requirements in conjunction with the applicable SaaS subscription tier of each customer and the timing of payments made to customers. Additional details pertaining to the Company's cashback program can be found in Part I, Item 1A. "Risk Factors" in our 2022 Annual Report. Subsequent to the date the 2022 Annual Report was filed with the SEC and effective as of March 2023, the Company removed a $25,000 monthly threshold for companies to qualify for 1% cash back and now offers a minimum of 1% cash back for all purchases.

Cost of Revenue, Net

Cost of revenue, net primarily consists of expenses related to hosting our service, including the costs of data center capacity, credit card processing fees, third-party software license fees, outsourcing costs to support customer service and outsourcing costs to support and process our patented scanning technology SmartScan, net of consideration from a vendor. Additional costs include amortization expense on capitalized software development costs and personnel-related expenses, including stock-based compensation and employee costs attributable to supporting our customers and maintenance of our platform.

Consideration from a vendor is related to the Expensify Card. We use a third-party vendor to issue Expensify Cards and process the related transactions. When purchases are made with the Expensify Card, a fee is charged by the card network to the merchant (also known as "interchange"). The vendor is contractually entitled to the interchange through its relationships with the card network and card issuing bank. The vendor keeps a portion of the interchange for their services, and our agreement with the vendor results in us receiving the remainder of the interchange less the amount retained by the vendor (our remainder portion, "Expensify interchange amount"). The vendor also charges us fees ("vendor fees") for the services it provides to us. Due to the nature of the vendor agreement, we do not record the Expensify interchange amount as revenue. Instead, the net of the Expensify interchange amount and vendor fees are paid to us, and we record it as "Consideration from a vendor, net," a contra expense in Cost of revenue, net. The following summarizes these various amounts for the periods presented:


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
	(in thousands)
Expensify interchange amount	$	2,657	$	1,708	$	4,918	$	2,928
Vendor fees	(254)		(160)		(443)		(257)
Consideration from a vendor, net	$	2,403	$	1,548	$	4,475	$	2,671

OPERATING EXPENSES

Research and Development

Research and development expenses consist primarily of personnel-related expenses, including stock-based compensation, incurred related to the planning and preliminary project stage and post-implementation stage of new products or enhancing existing products or services. We capitalize certain software development costs that are attributable to developing or adding significant functionality to our internal-use software during the application development stage of the projects. All research and development expenses, excluding capitalized software development costs, are expensed as incurred.


24

Table of Contents

We believe delivering new functionality is critical to attract new customers and expand our relationships with existing customers. We expect to continue to make investments in and expand our product and service offerings to enhance our customers’ experience and satisfaction and to attract new customers. We expect research and development expenses will increase as we expand our research and development team to develop new products and product enhancements.

General and Administrative

General and administrative expenses primarily consist of personnel-related expenses, including stock-based compensation, for any employee time allocated to administrative functions, including finance and accounting, legal and human resources. In addition to personnel-related expenses, general and administrative expenses consist of rent, utilities, depreciation on property and equipment, amortization of operating right-of-use assets and external professional services, including accounting, audit, tax, finance, legal and compliance, human resources and information technology. We expect that general and administrative expenses will continue to increase as we scale our business and as we incur additional costs associated with being a publicly traded company, including legal, audit, business insurance and consulting fees.

Sales and Marketing

Sales and marketing expenses primarily consist of personnel-related expenses, including stock-based compensation, advertising expenses, branding and public relations expenses and referral fees for strategic partners and other benefits that we provide to our referral and affiliate partners. We expect sales and marketing expenses will increase as we expand our sales efforts to pursue our market opportunity.

Interest and Other Expenses, Net

Interest and other expenses, net, consist primarily of interest paid under our credit facilities with Canadian Imperial Bank of Commerce ("CIBC"). It also includes realized gains and losses on foreign currency transactions and foreign currency remeasurement.

Provision for Income Taxes

Income taxes primarily consist of income taxes in the United States, United Kingdom, Australia, Netherlands and Canada, as well as states in the United States in which we do business.


25

Table of Contents

Results of Operations

The results of operations presented below should be reviewed in conjunction with the condensed consolidated financial statements and notes included elsewhere in this Quarterly Report on Form 10-Q.

The following table sets forth our results of operations for the periods presented:


	Three Months Ended June 30,						Six Months Ended June 30,
	2023			2022			2023			2022
	(in thousands, except percentages, share and per share data)
Revenue	$	38,884		$	43,162		$	78,985		$	83,532
Cost of revenue, net(1)	16,925			15,876			32,700			30,010
Gross margin	21,959			27,286			46,285			53,522
Operating expenses:
Research and development(1)	5,094			3,584			10,512			7,285
General and administrative(1)	11,712			15,432			24,141			29,438
Sales and marketing(1)	14,714			12,244			23,897			25,616
Total operating expenses	31,520			31,260			58,550			62,339
Loss from operations	(9,561)			(3,974)			(12,265)			(8,817)
Interest and other expenses, net	(1,367)			(1,955)			(2,783)			(2,856)
Loss before income taxes	(10,928)			(5,929)			(15,048)			(11,673)
Provision for income taxes	(376)			(2,065)			(2,201)			(3,697)
Net loss	$	(11,304)		$	(7,994)		$	(17,249)		$	(15,370)
Net loss per share:
Basic and diluted	$	(0.14)		$	(0.10)		$	(0.21)		$	(0.19)
Weighted average shares of common stock used to compute net loss per share:
Basic and diluted	82,011,477			80,473,097			81,890,624			80,311,053
Net loss margin	(29)		%	(19)		%	(22)		%	(18)		%

(1)Includes stock-based compensation expense as follows:


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
	(in thousands)
Cost of revenue, net	$	3,600	$	4,704	$	6,906	$	9,611
Research and development	2,455		1,877		4,661		4,298
General and administrative	2,376		5,463		5,020		10,439
Sales and marketing	1,910		2,004		3,758		4,080
Stock-based compensation expense	$	10,341	$	14,048	$	20,345	$	28,428


26

Table of Contents

COMPARISON OF THE THREE MONTHS ENDED JUNE 30, 2023 AND 2022

Revenue


	Three Months Ended June 30,				Change
	2023		2022		Amount		%
	(in thousands, except percentages)
Revenue	$	38,884	$	43,162	$	(4,278)	(10)	%

Revenue decreased by $4.3 million, or 10%, for the three months ended June 30, 2023 compared to the same period in 2022, primarily due to (i) a decrease in billable activity across our user base, including a decrease in pay-per-use billable activity which has a higher average fee per member than our annual members, and (ii) an increase in contra revenue related to cashback payments driven by the increased adoption and spend captured from members using the Expensify Card.

Cost of Revenue, Net and Gross Margin


	Three Months Ended June 30,						Change
	2023			2022			Amount		%
	(in thousands, except percentages)
Cost of revenue, net	$	16,925		$	15,876		$	1,049	7	%
Gross margin	$	21,959		$	27,286		$	(5,327)	(20)	%
Gross margin %	56		%	63		%

Cost of revenue, net increased by $1.0 million, or 7%, for the three months ended June 30, 2023 compared to the same period in 2022. Cost of revenue, net increased primarily due to increased outsourcing activities related to maintaining our platform. These increases were partially offset by an increase in Consideration from a vendor, net, driven primarily by the increased adoption and spend captured from members using the Expensify Card, which reduced Cost of revenue, net by $2.4 million and $1.5 million for the three months ended June 30, 2023 and 2022, respectively.

Gross margin decreased to 56% for the three months ended June 30, 2023 compared to 63% in the same period in 2022 primarily due to the decrease in Revenue due to the factors described in the preceding section.

OPERATING EXPENSES

Research and Development


	Three Months Ended June 30,				Change
	2023		2022		Amount		%
	(in thousands, except percentages)
Research and development	$	5,094	$	3,584	$	1,510	42	%

Research and development expenses increased by $1.5 million, or 42%, for the three months ended June 30, 2023 compared to the same period in 2022, primarily due to an increase in employee and external contributor time spent on project initiatives and new product features.


27

Table of Contents

General and Administrative


	Three Months Ended June 30,				Change
	2023		2022		Amount		%
	(in thousands, except percentages)
General and administrative	$	11,712	$	15,432	$	(3,720)	(24)	%

General and administrative expenses decreased by $3.7 million, or 24%, for the three months ended June 30, 2023 compared to the same period in 2022, primarily due to a decrease in employee time allocated to administrative functions resulting from one-time planning and implementation activities incurred in 2022 for first year compliance with Section 404 of the Sarbanes-Oxley Act and other new public company requirements.

Sales and Marketing


	Three Months Ended June 30,				Change
	2023		2022		Amount		%
	(in thousands, except percentages)
Sales and marketing	$	14,714	$	12,244	$	2,470	20	%

Sales and marketing expenses increased by $2.5 million, or 20%, for the three months ended June 30, 2023 compared to the same period in 2022, primarily due to (i) an increase in outsourcing activities related to sales and product demos, and (ii) an increase in marketing event spend to gain further brand awareness. These increases were partially offset by a decrease in advertising spend.

Interest and Other Expenses, Net


	Three Months Ended June 30,				Change
	2023		2022		Amount		%
	(in thousands, except percentages)
Interest and other expenses, net	$	(1,367)	$	(1,955)	$	588	(30)	%

Interest and other expenses, net decreased by $0.6 million, or 30%, for the three months ended June 30, 2023 compared to the same period in 2022, primarily due to a reduction in foreign currency losses, partially offset by an increase in interest expense incurred under the 2021 Amended Term Loan (as defined below) and revolving line of credit facility due to increases in CIBC's reference rate.


28

Table of Contents

Provision for Income Taxes


	Three Months Ended June 30,				Change
	2023		2022		Amount		%
	(in thousands, except percentages)
Provision for income taxes	$	(376)	$	(2,065)	$	1,689	(82)	%

We recorded a provision for income taxes of $0.4 million during the three months ended June 30, 2023 compared to a provision for income taxes of $2.1 million for the same period in 2022.

During the three months ended June 30, 2023 and 2022, our effective income tax rate was (3.4)% and (34.8)%, respectively. The effective income tax rate differs from the statutory rate in 2023 primarily due to non-deductible stock-based compensation, Section 162(m) of the Internal Revenue Code ("IRC") compensation limitations, and the change in valuation allowance. The effective income tax rate differs from the statutory rate in 2022 primarily due to the change in valuation allowance.

COMPARISON OF THE SIX MONTHS ENDED JUNE 30, 2023 and 2022


	Six Months Ended June 30,				Change
	2023		2022		Amount		%
	(in thousands, except percentages)
Revenue	$	78,985	$	83,532	$	(4,547)	(5)	%

Revenue decreased by $4.5 million, or 5%, for the six months ended June 30, 2023 compared to the same period in 2022, primarily due to (i) a decrease in pay-per-use billable activity which has a higher average fee per member than our annual members, and (ii) an increase in contra revenue related to cashback payments driven by the increased adoption and spend captured from members using the Expensify Card.

Cost of Revenue, Net and Gross Margin


	Six Months Ended June 30,						Change
	2023			2022			Amount		%
	(in thousands, except percentages)
Cost of revenue, net	$	32,700		$	30,010		$	2,690	9	%
Gross margin	$	46,285		$	53,522		$	(7,237)	(14)	%
Gross margin %	59		%	64		%

Cost of revenue, net increased by $2.7 million, or 9%, for the six months ended June 30, 2023 compared to the same period in 2022. Cost of revenue, net increased primarily due to increased outsourcing activities related to maintaining our platform. These increases were partially offset by an increase in Consideration from a vendor, net, driven primarily by the increased adoption and spend captured from members using the Expensify Card, which reduced Cost of revenue, net by $4.5 million and $2.7 million for the six months ended June 30, 2023 and 2022, respectively.

Gross margin decreased to 59% for the six months ended June 30, 2023 compared to 64% in the same period in 2022. Although revenue decreased by 5% for the same period, Cost of revenue, net, increased at a higher rate due to the factors described in the preceding paragraph.


29

Table of Contents

Research and Development


	Six Months Ended June 30,				Change
	2023		2022		Amount		%
	(in thousands, except percentages)
Research and development	$	10,512	$	7,285	$	3,227	44	%

Research and development expenses increased by $3.2 million, or 44%, for the six months ended June 30, 2023 compared to the same period in 2022, primarily due to an increase in employee and external contributor time spent on project initiatives and new product features.

General and Administrative


	Six Months Ended June 30,				Change
	2023		2022		Amount		%
	(in thousands, except percentages)
General and administrative	$	24,141	$	29,438	$	(5,297)	(18)	%

General and administrative expenses decreased by $5.3 million, or 18%, for the six months ended June 30, 2023 compared to the same period in 2022, primarily due to a decrease in employee time allocated to administrative functions resulting from one-time planning and implementation activities incurred in 2022 for first year compliance with Section 404 of the Sarbanes-Oxley Act and other new public company requirements.

Sales and Marketing


	Six Months Ended June 30,				Change
	2023		2022		Amount		%
	(in thousands, except percentages)
Sales and marketing	$	23,897	$	25,616	$	(1,719)	(7)	%

Sales and marketing expenses decreased by $1.7 million, or 7%, for the six months ended June 30, 2023 compared to the same period in 2022, primarily due to a decrease in advertising spend partially offset by (i) an increase in outsourcing activities related to sales and product demos, and (ii) marketing event spend to gain further brand awareness.

Interest and Other Expenses, Net


	Six Months Ended June 30,				Change
	2023		2022		Amount		%
	(in thousands, except percentages)
Interest and other expenses, net	$	(2,783)	$	(2,856)	$	73	(3)	%

Interest and other expenses, net decreased by $0.1 million, or 3%, for the six months ended June 30, 2023 compared to the same period in 2022, primarily due to a reduction in foreign currency losses partially offset by an increase in interest expense incurred under the 2021 Amended Term Loan (as defined below) and revolving line of credit facility due to increases in CIBC's reference rate.


30

Table of Contents

Provision for Income Taxes


	Six Months Ended June 30,				Change
	2023		2022		Amount		%
	(in thousands, except percentages)
Provision for income taxes	$	(2,201)	$	(3,697)	$	1,496	(40)	%

We recorded a provision for income taxes of $2.2 million during the six months ended June 30, 2023 compared to a provision for income taxes of $3.7 million for the same period in 2022.

During the six months ended June 30, 2023 and 2022, our effective income tax rate was (14.6)% and (31.7)%, respectively. The effective income tax rate differs from the statutory rate in 2023 primarily due to non-deductible stock-based compensation, Section 162(m) of the IRC compensation limitations, and the change in valuation allowance. The effective income tax rate differs from the statutory rate in 2022 primarily due to the change in valuation allowance.

Key Business Metrics and Non-GAAP Financial Measures

We supplement the reporting of our financial information determined under U.S. generally accepted accounting principles ("GAAP") with certain business metrics and non-GAAP financial measures which we regularly review to evaluate our business, measure our performance, identify trends affecting our business, formulate business plans and make strategic decisions. Accordingly, we believe that these key business metrics and non-GAAP financial measures provide useful information to investors and others in understanding and evaluating our results of operations in the same manner as our management team. These key business metrics and non-GAAP financial measures are presented for supplemental informational purposes only, should not be considered a substitute for our financial information presented in accordance with GAAP and may be different from similarly titled metrics or measures presented by other companies.

KEY BUSINESS METRICS

Paid Members

We believe that our ability to increase the number of paid members on our platform will drive our success as a business. Companies pay for subscriptions on behalf of employees and contractors who use the platform, whom we refer to as paid members. We define paid members as the average number of users (employees, contractors, volunteers, team members, etc.) who are billed on Collect or Control plans during any particular quarter. For small and medium businesses ("SMBs") or sole proprietors with only one employee, the business owner may also be the only paid member.

The following table sets forth the average number of paid members (in thousands):


Three Months Ended						Paid members
June 30, 2023						742
June 30, 2022						754


31

Table of Contents

NON-GAAP FINANCIAL MEASURES

Limitations of Non-GAAP Financial Measures

Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as substitutes for financial information presented under GAAP. There are a number of limitations related to the use of non-GAAP financial measures versus comparable financial measures determined under GAAP. For example, other companies in our industry may calculate these non-GAAP financial measures differently or may use other measures to evaluate their performance. All of these limitations could reduce the usefulness of these non-GAAP financial measures as analytical tools. Investors are encouraged to review the related GAAP financial measures and the reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures and to not rely on any single financial measure to evaluate our business.

Adjusted EBITDA and Adjusted EBITDA Margin

We define adjusted EBITDA as net loss from operations excluding provision for income taxes, interest and other expenses, net, depreciation and amortization and stock-based compensation. We define adjusted EBITDA margin as adjusted EBITDA divided by total revenue for the same period. We are focused on profitable growth and we consider adjusted EBITDA to be an important measure because it helps illustrate underlying trends in our business that could otherwise be masked by the effect of the income or expenses that are not indicative of the core operating performance of our business.


	Three Months Ended June 30,						Six Months Ended June 30,
	2023			2022			2023			2022
	(in thousands, except percentages)
Adjusted EBITDA	$	2,156		$	11,656		$	10,869		$	22,346
Adjusted EBITDA margin	6		%	27		%	14		%	27		%

Non-GAAP Net Income and Non-GAAP Net Income Margin

We define non-GAAP net income as net loss from operations in accordance with GAAP excluding stock-based compensation. We define non-GAAP net income margin as non-GAAP net income divided by total revenue for the same period. We are focused on profitable growth and we consider non-GAAP net income to be an important measure because it helps illustrate underlying trends in our business that could otherwise be masked by the effect of stock-based compensation expense, which is not considered indicative of the core operating performance of our business.


	Three Months Ended June 30,						Six Months Ended June 30,
	2023			2022			2023			2022
	(in thousands, except percentages)
Non-GAAP net (loss) income	$	(963)		$	6,054		$	3,096		$	13,058
Non-GAAP net (loss) income margin	(2)		%	14		%	4		%	16		%


32

Table of Contents

Reconciliations of Non-GAAP Financial Measures

The following tables reconcile the most directly comparable GAAP financial measure to each of these non-GAAP financial measures.

Adjusted EBITDA and Adjusted EBITDA Margin


	Three Months Ended June 30,						Six Months Ended June 30,
	2023			2022			2023			2022
	(in thousands, except percentages)
Net loss	$	(11,304)		$	(7,994)		$	(17,249)		$	(15,370)
Net loss margin	(29)		%	(19)		%	(22)		%	(18)		%
Add:
Provision for income taxes	376			2,065			2,201			3,697
Interest and other expenses, net	1,367			1,955			2,783			2,856
Depreciation and amortization	1,376			1,582			2,789			2,735
Stock-based compensation expense	10,341			14,048			20,345			28,428
Adjusted EBITDA	$	2,156		$	11,656		$	10,869		$	22,346
Adjusted EBITDA margin	6		%	27		%	14		%	27		%

Non-GAAP Net Income and Non-GAAP Net Income Margin


	Three Months Ended June 30,						Six Months Ended June 30,
	2023			2022			2023			2022
	(in thousands, except percentages)
Net loss	$	(11,304)		$	(7,994)		$	(17,249)		$	(15,370)
Net loss margin	(29)		%	(19)		%	(22)		%	(18)		%
Add:
Stock-based compensation expense	10,341			14,048			20,345			28,428
Non-GAAP net (loss) income	$	(963)		$	6,054		$	3,096		$	13,058
Non-GAAP net (loss) income margin	(2)		%	14		%	4		%	16		%

Liquidity and Capital Resources

Since our inception, we have financed our operations primarily through our cash flow from operations, sales of our equity securities and borrowings under our credit facilities. In November 2021, upon completion of our IPO, we received aggregate net proceeds of approximately $57.5 million after deducting underwriting discounts and commissions of approximately $4.9 million and offering costs of approximately $8.0 million. As of June 30, 2023, we had $97.8 million in cash and cash equivalents. As of June 30, 2023, we had $59.0 million in outstanding indebtedness.

Our future capital requirements will depend on many factors, including revenue growth and costs incurred to support growth in our business and our need to respond to business opportunities, challenges or unforeseen circumstances. We believe that our existing cash resources will be sufficient to finance our continued operations and growth strategy for the next 12 months and for the foreseeable future.


33

Table of Contents

CASH FLOWS

The following table summarizes our cash flows for the periods indicated:


	Six Months Ended June 30,
	2023		2022
	(in thousands)
Net cash provided by operating activities	$	7,208	$	27,158
Net cash used in investing activities	(2,522)		(735)
Net cash (used in) provided by financing activities	(11,040)		996
Net (decrease) increase in cash and cash equivalents and restricted cash	$	(6,354)	$	27,419

CASH FLOWS FROM OPERATING ACTIVITIES

Net cash provided by operating activities was $7.2 million for the six months ended June 30, 2023 compared to $27.2 million for the same period in 2022. The decrease was primarily due to a reduction in funds held for customers due to the timing of expense reimbursement activity, a decrease in revenue, increased outsourcing activities related to maintaining our platform, increased outsourcing activities related to sales and product demos, increased marketing event spend to gain further brand awareness, and a higher volume of payment processing fees directly related to an increase in reimbursement activity, partially offset by a decrease in advertising spend.

CASH FLOWS FROM INVESTING ACTIVITIES

During the six months ended June 30, 2023, net cash used in investing activities was $2.5 million, primarily consisting of software development costs and the purchase of property and equipment.

Net cash used in investing activities increased for the six months ended June 30, 2023 compared to the same period in 2022, primarily due to an increase in employee and external contributor software development costs.

CASH FLOWS FROM FINANCING ACTIVITIES

During the six months ended June 30, 2023, net cash used in financing activities was $11.0 million, primarily consisting of principal payments on the term loan, the repurchase and retirement of common stock, and payments for employees taxes withheld from stock-based awards, which was partially offset by proceeds from common stock purchased under the Company's 2021 Stock Purchase and Matching Plan ("Matching Plan").

During the six months ended June 30, 2022 net cash provided by financing activities primarily consisted of proceeds from common stock purchased under the Matching Plan and proceeds from the issuance of common stock on exercises of stock options, which was partially offset by principal payments on our term loan and finance leases.

CREDIT FACILITIES

Amortizing Term Mortgage

In August 2019, we entered into an $8.3 million amortizing term mortgage agreement with CIBC for our commercial building in Portland, Oregon. The agreement requires interest and principal payments be made each month over a 30-year period. Interest accrues at a fixed rate of 5.00% per year until August 2024, at which point the interest rate changes to the Wall Street Journal Prime Rate less 0.25% for the remaining term of the mortgage. The borrowings are secured by the building. The outstanding balance of the amortizing term mortgage was $7.8 million as of June 30, 2023.


34

Table of Contents

Loan and Security Agreement

In September 2021, we amended and restated our loan and security agreement with CIBC ("2021 Amended Term Loan") to refinance the existing non-amortizing and amortizing term loans, establish a single term loan of up to $75.0 million, consisting of a $45.0 million initial term loan effective immediately with an option to enter into an additional $30.0 million delayed term loan, and increase the monthly revolving line of credit to $25.0 million. The option for the delayed term loan expired in March 2023. The term loan and revolving line of credit mature in September 2026 and September 2024, respectively. Approximately $23.5 million of the loan proceeds were used to immediately repay the remaining balances under the amortizing and non-amortizing term loans at the time of the amendment, as well as commitment fees and other debt issuance costs associated with the amendment. The remaining proceeds from the initial term loan were utilized to fund our normal business operations.

Under the 2021 Amended Term Loan, the initial term loan of $45.0 million is payable over a 60 month period with principal and accrued interest payments due each quarter thereafter, which commenced with the first payment due on September 30, 2021. Quarterly principal payments are fixed and escalate throughout the term. The amounts borrowed bear interest at the bank’s reference rate plus 2.25% (10.50% as of June 30, 2023) and continue on a quarterly basis through the maturity of the term loan. The borrowings are secured by substantially all our assets. The outstanding balances of the 2021 Amended Term Loan and revolving line of credit were $36.2 million and $15.0 million, respectively, as of June 30, 2023.

See Note 4 to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for further information.

Certain Covenants

We are subject to customary covenants under the 2021 Amended Term Loan, which unless waived by CIBC, restrict our and our subsidiaries' ability to, among other things incur additional indebtedness, create or incur liens, permit a change of control or merge or consolidate with other companies, sell or transfer assets, pay dividends or make distributions, make acquisitions, investments or loans, or payments and prepayments of subordinated indebtedness, subject to certain exceptions. We must also maintain certain financial covenants: a total EBITDA net leverage ratio, as defined in the 2021 Amended Term Loan, tested each quarter, of not less than 5.00 to 1.00 from September 30, 2022 through and including June 30, 2023, not less than 4.00 to 1.00 from September 30, 2023 through and including June 30, 2024, and not less than 3.00 to 1.00 from September 30, 2024 and thereafter, and a fixed charge coverage ratio of not less than 1.10 to 1.00, tested on the last day of each calendar quarter.

If we fail to perform our obligations under these and other covenants, CIBC’s credit commitments could be terminated and any outstanding borrowings, together with accrued interest, under the credit or loan agreements could be declared immediately due and payable.

As of June 30, 2023, the Company was not in compliance with all debt covenants, specifically the covenant restricting the amount of repurchases of common stock, which includes RSU net share settlements, and the covenant related to the requirement to maintain all deposit, operating and collateral accounts with CIBC with certain exceptions during the period. A waiver was obtained from CIBC. The Company does not believe non-compliance with this covenant had any material impact on the Company or its operations. The Company expects to be in compliance with all debt covenants, or to have received waivers for any non-compliance, by the end of the fiscal quarter ending September 30, 2023.

Contractual Obligations and Commitments

As of June 30, 2023, there have been no material changes in our contractual obligations and commitments as disclosed in our 2022 Annual Report.


35

Table of Contents

Indemnification Agreements

In the ordinary course of business, we enter into agreements of varying scope and terms whereby we agree to indemnify customers, issuing banks, card networks, vendors and other parties with respect to certain matters, including, but not limited to, losses arising out of the breach of such agreements, services to be provided by us or from intellectual property infringement claims made by third parties. In addition, we have entered into indemnification agreements with our directors and certain officers and employees that will require us, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers or employees. No demands have been made upon us to provide indemnification under such agreements and there are no claims that we are aware of that could have a material effect on our Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Operations, Condensed Consolidated Statements of Changes in Stockholders’ Equity, or Condensed Consolidated Statements of Cash Flows.

Off-Balance Sheet Arrangements

During the periods presented, we did not have, and we do not currently have, any off-balance sheet financing arrangements or any relationships with unconsolidated entities or financial partnerships, including entities sometimes referred to as structured finance or special purpose entities, that were established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.

Critical Accounting Policies and Estimates

Our condensed consolidated financial statements included elsewhere herein have been prepared in accordance with GAAP. The preparation of our condensed consolidated financial statements requires us to make estimates and judgments that affect our reported amounts of assets, liabilities, revenues and expenses. We base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions.

There have been no material changes to our critical accounting policies and estimates as compared to those described in Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our 2022 Annual Report.

Recent Accounting Pronouncements

See Note 1 to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for recently adopted accounting pronouncements and recently issued accounting pronouncements not yet adopted as of the date of this Quarterly Report on Form 10-Q.

Emerging Growth Company Status

Upon the completion of our IPO, we elected to be an emerging growth company ("EGC"), as defined in the Jumpstart Our Business Startups Act of 2012, which, among other things, allowed us to take advantage of reduced disclosure requirements and an extended transition period for the implementation of new or revised accounting pronouncements.

Effective December 31, 2022, based on the market value of our common stock held by non-affiliates as of June 30, 2022, we were deemed to be a large accelerated filer and no longer qualified as an EGC. As a result, we must now comply with all financial disclosure and governance requirements applicable to large accelerated filers. The effect of the loss of EGC status and the impact on the adoption of new accounting pronouncements is discussed further in Note 2 to our consolidated financial statements in our 2022 Annual Report.


36

Table of Contents

Item 3. Quantitative and Qualitative Disclosures About Market Risk

There have been no material changes in our market risk from the disclosure included under Part II, Item 7A. “Quantitative and Qualitative Disclosures About Market Risk” in our 2022 Annual Report.

Item 4. Controls and Procedures

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

Our management, with the participation of our chief executive officer and chief financial officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended ("Exchange Act")), as of the end of the period covered by this Quarterly Report on Form 10-Q. Our disclosure controls and procedures are designed to provide reasonable assurance that information we are required to disclose in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosures, and is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Based on such evaluation, our chief executive officer and chief financial officer have concluded that as of June 30, 2023, our disclosure controls and procedures were effective at a reasonable assurance level.

CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING

There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rules 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

LIMITATIONS OF EFFECTIVENESS OF CONTROLS AND PROCEDURES

In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.


37

Table of Contents

Part II - Other Information

Item 1. Legal Proceedings

From time to time, we are involved in various legal proceedings arising from the normal course of business activities. We are not presently a party to any litigation the outcome of which, we believe, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, cash flows or financial condition. We have received, and may in the future continue to receive, claims from third parties asserting, among other things, infringement of their intellectual property rights. Defending such proceedings is costly and can impose a significant burden on management and employees. We may receive unfavorable preliminary or interim rulings in the course of litigation, and there can be no assurances that favorable final outcomes will be obtained. The results of any current or future litigation cannot be predicted with certainty, and regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors.

Item 1A. Risk Factors

There have been no material changes to the risk factors set forth in Part I, Item IA. "Risk Factors" of our 2022 Annual Report. You should carefully read and consider the risks and uncertainties, together with all of the other information included in the 2022 Annual Report and this Quarterly Report on Form 10-Q, including the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our condensed consolidated financial statements and related notes, and other documents that we file with the SEC.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

ISSUER PURCHASE OF EQUITY SECURITIES

The following table sets forth information regarding our purchases of shares of Class A common stock during the three months ended June 30, 2023.


	Total number of shares purchased	Weighted-average price paid per share		Total number of shares purchased as part of publicly announced programs	Maximum number (or approximate dollar value) of shares that may yet be purchased under the program(1)
April 1 - 30, 2023	—	$	—	—	$	44,000,000
May 1 - 31, 2023	504,493	$	5.93	504,493	$	41,000,003
June 1 - 30, 2023	—	$	—	—	$	41,000,003
Three months ended June 30, 2023	504,493			504,493

(1)On May 12, 2022, we announced the approval of a share repurchase program with authorization to purchase up to $50.0 million of our Class A common stock at management’s discretion. The repurchase program does not have an expiration date, does not obligate us to repurchase any specific number of shares and may be modified, suspended or terminated at any time at our discretion. At June 30, 2023, we had approximately $41.0 million remaining under the share repurchase authorization, not including amounts used for net share settlement of vested equity incentive awards.


38

Table of Contents

Item 3. Defaults Upon Senior Securities

None

Item 4. Mine Safety Disclosures

None

Item 5. Other Information

None.


39

Table of Contents

Item 6. Exhibits

Incorporated by Reference

Exhibit No.

Name

Form

File No.

Exhibit

Filing Date

3.1*

Amended and Restated Certificate of Incorporation of the Registrant.

3.2

Amended and Restated Bylaws of the Registrant.

8-K

001-41043

3.2

November 15, 2021

31.1*

Certification of the Principal Executive Officer, pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*

Certification of the Principal Financial Officer, pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1**

Certification of the Principal Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2**

Certification of the Principal Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS*

Inline XBRL Instance Document.

101.SCH*

Inline XBRL Taxonomy Extension Schema Document.

101.CAL*

Inline XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF*

Inline XBRL Taxonomy Extension Definition Linkbase Document.

101.PRE*

Inline XBRL Taxonomy Extension Presentation Linkable Document.

104*

Cover Page Interactive Data File (embedded within the Inline XBRL document).

Filed herewith.

Furnished herewith. The certifications attached as Exhibits 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q are deemed furnished and not filed with the SEC and are not to be incorporated by reference into any filing of the Company under the Securities Act or the Exchange Act, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.


40

Table of Contents

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



	EXPENSIFY, INC.

Date: August 9, 2023	By:	/s/ David Barrett
		David Barrett
		President and Chief Executive Officer
		(Principal Executive Officer)

Date: August 9, 2023	By:	/s/ Ryan Schaffer
		Ryan Schaffer
		Chief Financial Officer
		(Principal Financial Officer)

Exhibit 3.1

AMENDED AND RESTATED

CERTIFICATE OF INCORPORATION OF

EXPENSIFY, INC.

Expensify, Inc., a corporation organized and existing under the General Corporation Law of the State of Delaware (the “DGCL”), hereby certifies as follows:

1. The name of the corporation is Expensify, Inc. The date of the filing of its original certificate of incorporation with the Secretary of State of the State of Delaware was April 29, 2009.

2. This Amended and Restated Certificate of Incorporation (this “Certificate of Incorporation”), which restates, integrates and further amends the certificate of incorporation of this corporation as heretofore amended and restated, has been duly adopted by the corporation in accordance with Sections 242 and 245 of the DGCL and has been adopted by the requisite vote of the stockholders of the corporation, acting by written consent in lieu of a meeting in accordance with Section 228 of the DGCL.

3. The certificate of incorporation of this corporation is hereby amended and restated in its entirety to read as follows:

ARTICLE I

NAME

The name of the corporation is “Expensify, Inc.” (hereinafter called the “Corporation”).

ARTICLE II

REGISTERED OFFICE AND AGENT

The address of the Corporation’s registered office in the State of Delaware is 3500 South DuPont Highway, Dover, Delaware, County of Kent, 19901. The name of its registered agent at such address is Incorporating Services, Ltd.

ARTICLE III

PURPOSE

The purpose of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the DGCL.

ARTICLE IV

CAPITAL STOCK

Section 1. Authorized Shares.

The total number of shares of all classes of capital stock which the Corporation shall have authority to issue is 1,060,000,000 shares, consisting of one billion (1,000,000,000) shares of Class A Common Stock, par value $0.0001 per share (“Class A Common Stock”), 25 million (25,000,000) shares of LT10 Common Stock, par value $0.0001 per share (“LT10 Common Stock”), 25 million (25,000,000) shares of LT50 Common Stock, par value $0.0001 per share (“LT50 Common Stock,” and together with the LT10 Common Stock, the “LT Common Stock,” and together with the Class A Common Stock, the “Common Stock”), and ten million (10,000,000) shares of Preferred Stock, par value $0.0001 per share (“Preferred Stock”). Subject to the rights of holders of any series of Preferred Stock, the number of authorized shares of Class A Common Stock, LT10 Common Stock and LT50 Common Stock or Preferred Stock may be increased or decreased (but not below (i) the number of shares thereof then outstanding and (ii) with respect to the Class A Common Stock, the number of shares of Class A Common Stock reserved pursuant to Section 3(G)(ix) of this Article IV) by the affirmative vote of the holders of capital stock representing a majority of the voting power of all the then-outstanding shares of capital stock of the Corporation entitled to vote thereon irrespective of the provisions of Section 242(b)(2) of the DGCL.

Section 2. Preferred Stock

Preferred Stock may be issued from time to time in one or more series, each of such series to have such terms as stated or expressed herein and in the resolution or resolutions providing for the issue of such series adopted by the Board of Directors of the Corporation (the “Board”) as hereinafter provided. Subject to the rights of the holders of any series of Preferred Stock and except as otherwise provided by law, any shares of Preferred Stock that may be redeemed, purchased or acquired by the Corporation may be reissued by the Corporation.

Authority is hereby expressly granted to the Board from time to time to issue the Preferred Stock in one or more series and in connection with the creation of any such series, by adopting a resolution or resolutions providing for the issuance of the shares thereof and by filing a certificate of designations relating thereto in accordance with the DGCL, to determine and fix the number of shares of such series and such voting powers, full or limited, or no voting powers, and such designations, preferences and relative participating, optional or other special rights, and qualifications, limitations or restrictions thereof, including without limitation thereof, dividend rights, conversion rights, redemption privileges and liquidation preferences, as shall be stated and expressed in such resolutions, all to the full extent now or hereafter permitted by the DGCL. Without limiting the generality of the foregoing, the resolutions providing for issuance of any series of Preferred Stock may provide that such series shall be superior, equal or junior to any other series of Preferred Stock to the extent permitted by law.

Section 3. Common Stock

(A) Equal Status. Except as otherwise required by law or as expressly set forth in this Section 3 of Article IV, shares of Class A Common Stock, LT10 Common Stock and LT50 Common Stock shall have the same rights, privileges and powers, rank equally, share ratably and be identical in all respects as to all matters. The voting, dividend, liquidation and other rights, powers and preferences of the holders of Class A Common Stock, LT10 Common Stock and LT50 Common Stock are subject to, and qualified by, the rights, powers and preferences of holders of the Preferred Stock of any series as may be designated by the Board upon any issuance of the Preferred Stock of any series.

(B) Voting. Except as otherwise required by applicable law, at all meetings of stockholders and on all matters submitted to a vote of stockholders of the Corporation generally, each holder of Class A Common Stock, as such, shall have the right to one (1) vote per share of Class A Common Stock held of record by such holder, each holder of LT10 Common Stock, as such, shall have the right to ten (10) votes per share of LT10 Common Stock held of record by such holder, and each holder of LT50 Common Stock, as such, shall have the right to fifty (50) votes per share of LT50 Common Stock held of record by such holder. Except as otherwise required by applicable law or provided in this Certificate of Incorporation, the holders of shares of Class A Common Stock, LT10 Common Stock and LT50 Common Stock, as such, shall (i) at all times vote together as a single class on all matters (including the election of directors) submitted to a vote of the stockholders of the Corporation generally, (ii) be entitled to notice of any stockholders’ meeting in accordance with the Amended and Restated Bylaws of the Corporation (as the same may be amended and/or restated from time to time, the “Bylaws”), and (iii) be entitled to vote upon such matters and in such manner as may be provided by applicable law; provided, however, that, except as otherwise required by applicable law, holders of Class A Common Stock, LT10 Common Stock and LT50 Common Stock, as such, shall not be entitled to vote on any amendment to this Certificate of Incorporation that relates solely to the terms of one or more outstanding series of Preferred Stock if the holders of such affected series are entitled, either separately or together with the holders of one or more other such series, to vote thereon pursuant to this Certificate of Incorporation or applicable law. There shall be no cumulative voting.

(C) Dividend Rights. Subject to applicable law and the rights, if any, of the holders of any outstanding series of Preferred Stock or any class or series of stock having a preference over or the right to participate with the Class A Common Stock, LT10 Common Stock or LT50 Common Stock with respect to the payment of dividends in cash, property or shares of capital stock of the Corporation, dividends may be declared and paid on the shares of Class A Common Stock, LT10 Common Stock or LT50 Common Stock, out of any assets of the Corporation legally available therefore at such times and in such amounts as the Board in its discretion shall determine; provided, however, that in the event a dividend is paid in the form of shares of Class A Common Stock, LT10 Common Stock or LT50 Common Stock (or in rights to acquire, or securities convertible into or exchangeable for, such shares), then holders of Class A Common Stock shall be entitled to receive shares of Class A Common Stock (or rights to acquire, or securities convertible into or exchangeable for, such shares, as the case may be), holders of LT10 Common Stock shall be entitled to receive shares of LT10 Common Stock (or rights to acquire, or securities convertible into or exchangeable for, such shares, as the case may be), and holders

of LT50 Common Stock shall be entitled to receive shares of LT50 Common Stock (or rights to acquire, or securities convertible into or exchangeable for, such shares, as the case may be), with holders of shares of Class A Common Stock, LT10 Common Stock and LT50 Common Stock receiving, on a per share basis, an identical number of shares of Class A Common Stock, LT10 Common Stock or LT50 Common Stock as the case may be (or rights to acquire, or securities convertible into or exchangeable for, such shares, as the case may be), as applicable. Notwithstanding the foregoing, the Board may declare and the Corporation may pay a disparate dividend per share of Class A Common Stock, LT10 Common Stock or LT50 Common Stock (whether the disparity shall be in the amount of such dividend payable per share, the form in which such dividend is payable (whether it shall be payable in cash, shares of capital stock of the Corporation, other securities of the Corporation, or any combination of the foregoing), the timing of the payment, or otherwise).

(D) Subdivisions, Combinations or Reclassifications. Shares of Class A Common Stock, LT10 Common Stock and LT50 Common Stock may not be subdivided, combined or reclassified unless the shares of the other classes are concurrently therewith proportionately subdivided, combined or reclassified in a manner that maintains the same proportionate equity ownership between the holders of the outstanding Class A Common Stock, LT10 Common Stock and LT50 Common Stock on the record date for such subdivision, combination or reclassification; provided, however, that shares of one such class may be subdivided, combined or reclassified in a different or disproportionate manner if such subdivision, combination or reclassification is approved by the affirmative vote of the holders of a majority of the outstanding shares of Class A Common Stock, LT10 Common Stock and LT50 Common Stock, each voting separately as a class.

(E) Liquidation, Dissolution or Winding Up. Subject to the preferential or other rights of any holders of Preferred Stock then outstanding, upon the dissolution, distribution of assets, liquidation or winding up of the Corporation, whether voluntary or involuntary, holders of Class A Common Stock, LT10 Common Stock and LT50 Common Stock will be entitled to receive ratably all assets of the Corporation available for distribution to its stockholders unless disparate or different treatment of the shares of each such class with respect to distributions upon any such liquidation, dissolution, distribution of assets or winding up is approved by the affirmative vote of the holders of a majority of the outstanding shares of Class A Common Stock, LT10 Common Stock and LT50 Common Stock, each voting separately as a class.

(F) Restrictions on Transfers of Shares of LT Common Stock.

(i) To the maximum extent permitted under applicable law, no holder of LT Common Stock shall Transfer any shares of LT Common Stock to any person or entity unless the requirements set forth in Section 3(H) of this Article IV have been satisfied. “Transfer” of a share of LT Common Stock means any sale, contract to sell, assignment, transfer, conveyance, hypothecation, pledge, sale of any option or contract to purchase, purchase of any option or contract to sell, grant of any option, right or warrant to purchase, hedging, swap or other agreement or transaction that transfers, in whole or in part, any of the economic consequences of ownership, (including, without limitation, any short sale or the purchase or sale of, or entry into, any put or call option, or combination thereof, forward, swap or any other derivative transaction or instrument, however described or defined), loan, or other transfer or disposition of such share

or any legal or beneficial interest in such share, whether or not for value, whether direct or indirect, whether any such transaction is to be settled by delivery of such share of LT Common Stock, in cash or otherwise, and whether voluntary or involuntary or by operation of law, and shall include, without limitation, (a) a transfer of a share of LT Common Stock to a broker or other nominee (regardless of whether or not there is a corresponding change in beneficial ownership) or (b) the transfer of, or entering into a binding agreement with respect to, the exclusive power (whether directly or indirectly) to vote or direct the voting of such share of LT Common Stock, including by proxy, voting agreement or otherwise; provided, however, that a “Transfer” shall not include: (1) the grant of a proxy to officers or directors of the Corporation at the request of the Board in connection with actions to be taken at an annual or special meeting of stockholders; (2) any Transfer to or by the trust (the “Expensify Voting Trust”) established under that certain Voting Trust Agreement, dated as of November 9, 2021, by and between the Company and the holders named therein (as it may be amended and/or restated from time to time in accordance with its terms, the “Voting Trust Agreement”); (3) a Transfer to a decedent’s estate upon the death of a holder of LT Common Stock; (4) an Exchange as defined in and pursuant to Section 3(H)(iii) of this Article IV; or (5) the fact that the spouse of any holder of LT Common Stock possesses or obtains an interest in such holder’s shares of LT Common Stock arising solely by reason of the application of the property transfer laws of any jurisdiction, so long as no other event or circumstance shall exist or have occurred that constitutes a Transfer of such shares of LT Common Stock.

(ii) Notwithstanding the foregoing, the Board shall be able to waive, upon the affirmative vote of a majority of the members of the Board, any or all of the requirements of Section 3(H) of this Article IV with respect to the Transfer of any shares of LT Common Stock.

(iii) Any Transfer of shares of LT Common Stock not made in accordance with this Section 3(F) and Section 3(H), or pursuant to Section 3(G), of this Article IV shall be void ab initio, and the Corporation shall not treat the transferee in such transaction as a holder of such shares for any purpose.

(G) Conversion of LT Common Stock.

(i) Optional Conversion by Holder of LT Common Stock. Each share of LT Common Stock shall be convertible into one (1) fully paid and nonassessable share of Class A Common Stock at the option of the holder thereof solely upon the satisfaction of and subject to the requirements set forth in Section 3(H) of this Article IV.

(ii) Automatic Conversion Upon Certain Transfers. Except in the case of a Non-Converting Transfer, each share of LT Common Stock shall automatically, without further action by the Corporation or the holder thereof, convert into one (1) fully paid and nonassessable share of Class A Common Stock upon the occurrence of a Transfer of such share of LT Common Stock, provided that such Transfer is made in compliance with the requirements outlined in Section 3(F) and Section 3(H) of this Article IV. For the avoidance of doubt, any Transfer of shares of LT Common Stock not made in accordance with such provisions shall be void and the Corporation shall not treat the transferee in such transaction as a holder of such shares for any purposes. A “Non-Converting Transfer” means a Transfer of shares of LT Common Stock (i) to be held in trust by the Trustees of the Expensify Voting Trust; (ii) in an Exchange as defined in

and pursuant to Section 3(H)(iii) of this Article IV; (iii) to the estate of a decedent holder of LT Common Stock, upon such holder’s death; or (iv) approved in advance by the affirmative vote of a majority of the members of the Board.

(iii) Automatic Conversion Upon Reduction in Outstanding Shares. Each outstanding share of LT Common Stock shall automatically, without further action by the Corporation or the holder thereof, convert into one (1) fully paid and nonassessable share of Class A Common Stock upon the first date on which the then-outstanding shares of LT Common Stock represent less than two percent (2%) of all then-outstanding shares of Common Stock.

(iv) Policies and Procedures. The Corporation may, from time to time, establish such policies and procedures, not in violation of applicable law or the other provisions of this Certificate of Incorporation, relating to the conversion of the LT Common Stock into Class A Common Stock and the general administration of this multi-class stock structure, including the issuance of stock certificates with respect thereto, as it may deem necessary or advisable, and may from time to time request that holders of shares of LT Common Stock furnish such certifications, affidavits or other proof to the Corporation as it deems necessary to verify the ownership of LT Common Stock and to confirm that a conversion to Class A Common Stock has not previously occurred. A determination by the Board that a Transfer has resulted or will result in a conversion of the LT Common Stock to Class A Common Stock shall be conclusive and binding on all persons to the fullest extent permitted by law.

(v) Status of Converted Stock. In the event any shares of LT Common Stock are converted into shares of Class A Common Stock pursuant to this Section 3, the shares of LT Common Stock so converted shall be retired and shall not be reissued by the Corporation.

(vi) Effect of Conversion on Payment of Dividends. Notwithstanding anything to the contrary in this Section 3(G), if the date on which any share of LT Common Stock is converted into Class A Common Stock pursuant to the provisions of this Section 3(G) occurs after the record date for the determination of holders of LT Common Stock entitled to receive any dividend to be paid on the shares of LT Common Stock, the holder of such shares of LT Common Stock as of such record date will be entitled to receive such dividend on such payment date; provided, that, notwithstanding any other provision of this Certificate of Incorporation, to the extent that any such dividend is payable in shares of LT Common Stock (or rights to acquire, or securities convertible into or exchangeable for, such shares, as the case may be), such dividend shall be deemed to have been declared, and shall be payable in, shares of Class A Common Stock (or rights to acquire, or securities convertible into or exchangeable for, such shares, as the case may be), and no shares of LT Common Stock shall be issued in payment thereof.

(ix) Shares Reserved for Issuance. The Corporation shall at all times reserve and keep available out of its authorized but unissued shares of Class A Common Stock, solely for the purpose of effecting the conversion of the shares of LT Common Stock, such number of shares of Class A Common Stock as shall from time to time be sufficient to effect the conversion of all outstanding shares of LT Common Stock into shares of Class A Common Stock.

(H) LT Common Stock Transfer and Conversion Requirements.

(i) Notice Requirement. Before any shares of LT Common Stock shall be converted into shares of Class A Common Stock pursuant to Section 3(G)(i) of this Article IV or Transferred pursuant to Section 3(F) of this Article IV, the holder of such shares, or if such shares are held in the Expensify Voting Trust, the beneficial holder of such shares, shall provide written notice of such conversion or Transfer intent, delivered simultaneously to the Trustees (as defined in the Voting Trust Agreement) of the Expensify Voting Trust in the manner set forth in the Voting Trust Agreement and to the Corporation at its principal corporate office, and shall state therein the number of shares of LT10 Common Stock and/or LT50 Common Stock to be so converted or Transferred. From and after the time that a holder of LT Common Stock is no longer an employee of or other service provider to the Corporation or any of its subsidiaries, the Corporation shall have the right to submit a written notice of conversion on such holder’s behalf, without the consent of such holder, delivered to the holder at the address of such holder set forth in the Company’s books and records.

(ii) Notice Period. The “Notice Period” for each share of LT10 Common Stock shall be ten (10) months, and for each share of LT50 Common Stock shall be fifty (50) months, following the receipt of notice as set forth in Section 3(H)(i) of this Article IV.

(iii) Exchange. During the applicable Notice Period, the Trustees shall attempt to identify a holder of shares of Class A Common Stock who is an employee of or other service provider to the Corporation or a subsidiary and is interested in exchanging shares of Class A Common Stock (a “Class A Transferor”) for the shares of LT Common Stock subject to the notice, on a one-for-one basis (an “Exchange”). If a Class A Transferor is identified, the Trustees shall provide written notice to the holder of shares of LT Common Stock seeking to convert or Transfer shares of LT Common Stock pursuant to this Section 3(H) (the “LT Holder”), the Class A Transferor and the Corporation, at its principal corporate office, stating the names of such LT Holder and Class A Transferor, the date on which the applicable notice period expires (the “Notice Expiration Date”), and any applicable instructions to facilitate the Exchange. Prior to the Notice Expiration Date, (x) the Class A Transferor shall be required to deliver to the Corporation a written instrument or instruments of transfer with respect to the shares of Class A Common Stock that are the subject of the Exchange, in form satisfactory to the Corporation, duly executed by such Class A Transferor, as well as, if applicable, a certificate or certificates representing such shares, provided, however, that if such shares of Class A Common Stock are held in the Expensify Voting Trust, such items shall be provided by the Trustees, (y) the LT Holder shall be required to deliver to the Trustees any written instrument or instruments requested by the Trustees, and (z) if the Class A Transferor is not a party to the Voting Trust Agreement, the Class A Transferor shall deliver to the Trustees an executed joinder agreement such that following the Exchange the Class A Transferor shall be a party to the Voting Trust Agreement and the shares of LT Common Stock subject to the Exchange shall remain in the Voting Trust. The Exchange shall be deemed effective immediately prior to the close of business on the first business day following the Notice Expiration Date; provided, however, that the Corporation may extend such effective date by up to five (5) days if necessary to effectuate the Exchange (such date, the “Effective Date”). The Corporation shall, as soon as practicable after the Effective Date, issue and deliver to such LT Holder a certificate or certificates representing the number of shares of Class A Common Stock to which such holder is entitled upon the Exchange (if such shares of

Class A Common Stock are certificated) or shall register such shares of Class A Common Stock in book-entry form (if such shares of Class A Common Stock are uncertificated), and the Trustees shall revise the Trust Register (as defined in the Voting Trust Agreement) accordingly, in each case effective as of the Effective Date.

(iv) Conversion of LT Common Stock if No Exchange. If the Trustees are unable to identify a Class A Transferor to participate in an Exchange prior to the Notice Expiration Date, they shall provide written notice to the Corporation no later than one business day prior to the Notice Expiration Date, and the Corporation shall, as soon as practicable following the Notice Expiration Date, effectuate the conversion of the shares of LT Common Stock subject to the notice into shares of Class A Common Stock on a one-for-one basis in accordance with this Section 3(H)(iv). In the event of such a conversion, as soon as practicable following the Notice Expiration Date, the holder of record of LT Common Stock shall surrender the certificate or certificates therefor (if any), duly endorsed, at the principal corporate office of the Corporation and shall provide written notice (the “Conversion Notice”) to the Corporation at its principal corporate office stating therein the name or names (i) in which the certificate or certificates representing the shares of Class A Common Stock into which the shares of LT Common Stock being converted are to be issued (if such shares of Class A Common Stock are certificated), or (ii) in which such shares of Class A Common Stock are to be registered in book-entry form (if such shares of Class A Common Stock are uncertificated). If the shares of Class A Common Stock into which shares of LT Common Stock are to be converted are to be issued in a name or names other than the name of the beneficial holder of the shares of LT Common Stock being converted, such notice shall be accompanied by a written instrument or instruments of transfer, in form satisfactory to the Corporation, duly executed by the holder. The Corporation shall, as soon as practicable thereafter, issue and deliver to such holder, or to the nominee or nominees of such holder, a certificate or certificates representing the number of shares of Class A Common Stock to which such holder shall be entitled upon conversion (if such shares of Class A Common Stock are certificated) or shall register such shares of Class A Common Stock in book-entry form (if such shares of Class A Common Stock are uncertificated). Any such conversion shall be deemed effective immediately prior to the close of business on the date of such surrender of the shares of LT Common Stock to be converted(the “Conversion Effective Time”), which may occur following or contemporaneously with the provision of the Conversion Notice. The shares of Class A Common Stock issuable upon such conversion shall be deemed outstanding as of the Conversion Effective Time, and the person or persons entitled to receive the shares of Class A Common Stock issuable upon such conversion shall be deemed to be the record holder or holders of such shares of Class A Common Stock as of the Conversion Effective Time.

ARTICLE V

AMENDMENT OF THE CERTIFICATE OF INCORPORATION

The Corporation reserves the right to amend, alter, change, adopt or repeal any provision contained in this Certificate of Incorporation, in the manner now or hereafter prescribed by statute, and all rights conferred upon stockholders herein are granted subject to this reservation; provided, however, that notwithstanding any other provision of this Certificate of Incorporation or any provision of law that might otherwise permit a lesser vote or no vote, but in addition to

any vote of the holders of shares of any class or series of capital stock of the Corporation required by law or by this Certificate of Incorporation:

(A) so long as any shares of LT10 Common Stock remain outstanding, the Corporation shall not, without the prior affirmative vote of the holders of a majority of the outstanding shares of LT10 Common Stock, voting as a separate class, in addition to any other vote required by applicable law or this Certificate of Incorporation, directly or indirectly, whether by amendment, or through merger, recapitalization, consolidation or otherwise, amend, alter, change, repeal or adopt any provision of this Certificate of Incorporation (1) that alters or changes, any of the voting, conversion, dividend or liquidation provisions of the shares of LT10 Common Stock or other rights, powers, preferences or privileges of the shares of LT10 Common Stock; (2) to provide for each share of LT50 Common Stock to have more than fifty (50) votes per share or for each share of Class A Common Stock to have more than one (1) vote per share or any rights to a separate class vote of the holders of the LT50 Common Stock or the shares of Class A Common Stock other than as provided by this Certificate of Incorporation or required by the DGCL; or (3) to otherwise adversely impact the rights, powers, preferences or privileges of the shares of LT10 Common Stock in a manner that is disparate from the manner in which it affects the rights, powers, preferences or privileges of the shares of LT50 Common Stock or the shares of Class A Common Stock;

(B) so long as any shares of LT50 Common Stock remain outstanding, the Corporation shall not, without the prior affirmative vote of the holders of a majority of the outstanding shares of LT50 Common Stock, voting as a separate class, in addition to any other vote required by applicable law or this Certificate of Incorporation, directly or indirectly, whether by amendment, or through merger, recapitalization, consolidation or otherwise, amend, alter, change, repeal or adopt any provision of this Certificate of Incorporation (1) that alters or changes, any of the voting, conversion, dividend or liquidation provisions of the shares of LT50 Common Stock or other rights, powers, preferences or privileges of the shares of LT50 Common Stock; (2) to provide for each share of LT10 Common Stock to have more than ten (10) votes per share or for each share of Class A Common Stock to have more than one (1) vote per share or any rights to a separate class vote of the holders of the LT10 Common Stock or the shares of Class A Common Stock other than as provided by this Certificate of Incorporation or required by the DGCL; or (3) to otherwise adversely impact the rights, powers, preferences or privileges of the shares of LT50 Common Stock in a manner that is disparate from the manner in which it affects the rights, powers, preferences or privileges of the shares of LT10 Common Stock or the shares of Class A Common Stock; and

(C) so long as any shares of Class A Common Stock remain outstanding, the Corporation shall not, without the prior affirmative vote of the holders of a majority of the outstanding shares of Class A Common Stock, voting as a separate class, in addition to any other vote required by applicable law or this Certificate of Incorporation, directly or indirectly, whether by amendment, or through merger, recapitalization, consolidation or otherwise, amend, alter, change, repeal or adopt any provision of this Certificate of Incorporation to provide for each share of LT10 Common Stock to have more than ten (10) votes per share or for each share of LT50 Common Stock to have more than fifty (50) votes per share or for any rights to a separate class vote of the holders of shares of LT10 Common Stock or LT50 Common Stock, or of LT10 Common Stock

and LT50 Common Stock voting together as a single class, other than as provided by this Certificate of Incorporation or required by the DGCL.

ARTICLE VI

AMENDMENT OF BYLAWS

In furtherance and not in limitation of the powers conferred by the DGCL, the Board shall have the power to adopt, amend, alter or repeal the Bylaws. The stockholders shall also have the power to adopt, amend, alter or repeal the Bylaws; provided, however, that in addition to any vote of the holders of any class or series of stock of the Corporation required by law or by this Certificate of Incorporation, such action by stockholders shall require the affirmative vote of the holders of at least a majority of the voting power of all of the then-outstanding shares of capital stock of the corporation entitled to vote generally in the election of directors, voting together as a single class.

ARTICLE VII

BOARD OF DIRECTORS

Section 1. Number of Directors.

(A) The business and affairs of the Corporation shall be managed by or under the direction of the Board, except as otherwise provided by law.

(B) Subject to the rights of holders of any series of Preferred Stock to elect directors, the number of the directors of the Corporation shall be fixed from time to time by resolution of the Board, but shall initially be eight (8) members. Unless and except to the extent that the Bylaws shall so require, the election of directors of the Corporation need not be by written ballot.

Section 2. Terms of Office.

Subject to the rights of holders of any series of Preferred Stock to elect directors, each director shall serve for a term ending on the date of the next annual meeting of stockholders following the annual meeting of stockholders at which such director was elected; provided, further, that the term of each director shall continue until the election and qualification of his or her successor and be subject to his or her earlier death, disqualification, resignation or removal.

Section 3. Vacancies

Subject to the rights of holders of any series of Preferred Stock, any newly created directorship that results from an increase in the number of directors or any vacancies on the Board that result from the death, resignation, disqualification or removal from office or from any other cause shall be filled solely by the affirmative vote of a majority of the members of the Board then in office, even if less than a quorum of the Board, or by a sole remaining director, and shall not be filled by the stockholders. Any director so chosen shall hold office until his or her successor shall be duly elected and qualified or until his or her earlier death, disqualification, resignation or removal.

Section 4. Removal

Subject to the rights of the holders of any series of Preferred Stock, any director may be removed from office at any time, with or without cause, by the affirmative vote of stockholders holding at least a majority in voting power of the shares of capital stock of the Corporation then entitled to vote generally in the election of directors, voting together as a single class.

Section 5. Committees

For as long as the Expensify Voting Trust holds securities representing at least 50% of the voting power of outstanding capital stock of the Corporation, there shall be an Executive Committee of the Board, consisting of five (5) directors of the Corporation, which shall have and may exercise all the powers and authority of the Board in the management of the business and affairs of the Corporation, and may authorize the seal of the Corporation to be affixed to all papers that may require it; provided that such committee shall not have power or authority in reference to the following matters: (i) matters that must be approved by an Audit Committee of the Board, (ii) matters that must be approved by a committee qualified to grant equity to persons subject to Section 16 of the Securities and Exchange Act of 1934, as amended, for purposes of exempting transactions pursuant to Section 16b-3 thereunder, (iii) matters required under the DGCL to be approved by the full Board, or (iv) as otherwise required by SEC rules and the Stock Exchange Rules. The Executive Committee may not delegate any or all of its powers and authority to a subcommittee.

Section 6. Stockholder Nominations and Introduction of Business.

Advance notice of stockholder nominations for election of directors and other business to be brought by stockholders before a meeting of stockholders shall be given in the manner provided by the Bylaws.

Section 7. Preferred Stock Directors.

During any period when the holders of any series of Preferred Stock have the right to elect additional directors as provided for or fixed pursuant to the provisions of Article IV hereof or any certificate of designation of any series of Preferred Stock, then upon commencement and for the duration of the period during which such right continues: (i) the then otherwise total number of authorized directors of the Corporation shall automatically be increased by such specified number of directors, and the holders of such Preferred Stock shall be entitled to elect the additional directors so provided for or fixed pursuant to said provisions, and (ii) each such additional director shall serve until such director’s successor shall have been duly elected and qualified, or until such director’s right to hold such office terminates pursuant to said provisions, whichever occurs earlier, subject to his earlier death, disqualification, resignation or removal. Except as otherwise provided for or fixed pursuant to the provisions of Article IV hereof or any certificate of designation of any series of Preferred Stock, whenever the holders of any series of Preferred Stock having such right to elect additional directors are divested of such right pursuant to the provisions of such stock, all such additional directors elected by the holders of such stock, or elected or appointed to fill any vacancies resulting from the death, resignation, disqualification or removal of such additional directors shall automatically cease to be qualified as directors, the

terms of office of all such directors shall forthwith terminate and the total authorized number of directors of the Corporation shall be reduced accordingly.

ARTICLE VIII

LIMITATION OF DIRECTOR LIABILITY

To the fullest extent permitted by the DGCL as the same exists or as may hereafter be amended, a director of the Corporation shall not be personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director; provided, however, that nothing contained in this Article VIII shall eliminate or limit the liability of a director (i) for any breach of the director’s duty of loyalty to the Corporation or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) pursuant to the provisions of Section 174 of the DGCL, or (iv) for any transaction from which the director derived an improper personal benefit. If the DGCL is amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of a director of the Corporation shall be eliminated or limited to the fullest extent permitted by the DGCL, as so amended. No amendment, repeal or modification of this Article VIII shall apply to or have any adverse effect on any right or protection of, or any limitation of the liability of, a director of the Corporation existing at the time of such amendment, repeal or modification with respect to acts or omissions occurring prior to such repeal or modification.

ARTICLE IX

INDEMNIFICATION

The Corporation shall have the power to provide rights to indemnification and advancement of expenses to its current and former officers, directors, employees and agents and to any person who is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise.

ARTICLE X

CONSENT OF STOCKHOLDERS IN LIEU OF MEETING

Subject to the terms of any series of Preferred Stock, (i) prior to the date on which the Expensify Voting Trust ceases to hold securities representing at least a majority of the voting power of outstanding capital stock of the Corporation, any action required or permitted to be taken by the stockholders of the Corporation may be effected by consent in lieu of a meeting and (ii) following such date, any action required or permitted to be taken by the stockholders of the Corporation must be effected at an annual or special meeting of the stockholders and may not be effected by consent in lieu of a meeting.

ARTICLE XI

SPECIAL MEETING OF STOCKHOLDERS

Subject to the terms of any series of Preferred Stock, special meetings of stockholders for any purpose or purposes may be called at any time by or at the direction of (i) the Board, (ii) the Chairman of the Board, (iii) the Chief Executive Officer of the Corporation or (iv) prior to the date on which the Expensify Voting Trust ceases to hold securities representing at least a majority of the voting power of outstanding capital stock of the Corporation, the holders of a majority of the total voting power of the outstanding shares of capital stock of the Corporation entitled to vote generally in the election of directors. Business transacted at any special meeting of stockholders shall be limited to matters relating to the purpose or purposes stated in the notice of meeting.

ARTICLE XII

FORUM SELECTION

Unless the Corporation consents in writing to the selection of an alternative forum, (a) the Court of Chancery (the “Chancery Court”) of the State of Delaware (or, in the event that the Chancery Court does not have jurisdiction, the federal district court for the District of Delaware or other state courts of the State of Delaware) shall, to the fullest extent permitted by law, be the sole and exclusive forum for (i) any derivative action, suit or proceeding brought on behalf of the Corporation, (ii) any action, suit or proceeding asserting a claim of breach of a fiduciary duty owed by any current or former director, officer, other employee or stockholder of the Corporation to the Corporation or to the Corporation’s stockholders, (iii) any action, suit or proceeding arising pursuant to any provision of the DGCL or the bylaws of the Corporation or this Restated Certificate (as either may be amended or restated from time to time) or as to which the DGCL confers jurisdiction on the Chancery Court or (iv) any action, suit or proceeding asserting a claim against the Corporation governed by the internal affairs doctrine of the law of the State of Delaware; and (b) subject to the preceding provisions of this Article X, the federal district courts of the United States of America shall be the exclusive forum for the resolution of any complaint asserting a cause or causes of action arising under the Securities Act of 1933, as amended. If any action the subject matter of which is within the scope of clause (a) of the immediately preceding sentence is filed in a court other than the courts in the State of Delaware (a “Foreign Action”) in the name of any stockholder, such stockholder shall be deemed to have consented to (x) the personal jurisdiction of the state and federal courts in the State of Delaware in connection with any action brought in any such court to enforce the provisions of clause (a) of the immediately preceding sentence and (y) having service of process made upon such stockholder in any such action by service upon such stockholder’s counsel in the Foreign Action as agent for such stockholder.

Any person or entity purchasing or otherwise acquiring or holding any interest in any security of the Corporation shall be deemed to have notice of and consented to this Article X. Notwithstanding the foregoing, the provisions of this Article X shall not apply to suits brought to enforce any liability or duty created by the Securities Exchange Act of 1934, as amended, or any other claim for which the federal courts of the United States have exclusive jurisdiction.

If any provision or provisions of this Article X shall be held to be invalid, illegal or unenforceable as applied to any circumstance for any reason whatsoever, (a) the validity, legality and enforceability of such provisions in any other circumstance and of the remaining provisions of this Article X (including, without limitation, each portion of any paragraph of this Article X containing any such provision held to be invalid, illegal or unenforceable that is not itself held to be invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and (b) the application of such provision to other persons or entities and circumstances shall not in any way be affected or impaired thereby.

* * *

IN WITNESS WHEREOF, this Amended and Restated Certificate of Incorporation has been executed this 15th day of November, 2021.


EXPENSIFY, INC.


	By:	/s/ David Barrett
		Name:	David Barrett
		Title:	Chief Executive Officer

CERTIFICATE OF RETIREMENT

670 SHARES OF LT10 COMMON STOCK

EXPENSIFY, INC.

Pursuant to Section 243(b)

of the General Corporation Law

of the State of Delaware

Expensify, Inc., a corporation organized and existing under the General Corporation Law of the State of Delaware (the “DGCL”) (hereinafter the “Corporation”), hereby certifies as follows:

1.670 outstanding shares of LT10 Common Stock, par value $0.0001 per share (“LT10 Common Stock”), of the Corporation have been converted into 670 shares of Class A Common Stock, par value $0.0001 per share (“Class A Common Stock”), of the Corporation.

2.The Amended and Restated Certificate of Incorporation of the Corporation filed with the Secretary of State of the State of Delaware on November 15, 2021 provides that any shares of LT10 Common Stock which are converted into shares of Class A Common Stock shall be retired and may not be reissued by the Corporation.

3.The Board of Directors of the Corporation has adopted resolutions retiring the 670 shares of LT10 Common Stock that converted into 670 shares of Class A Common Stock.

4.Accordingly, pursuant to the provisions of Section 243(b) of the DGCL, upon the filing of this Certificate of Retirement the Amended and Restated Certificate of Incorporation of the Corporation shall be amended so as to reduce the total authorized number of shares of the capital stock of the Corporation by 670 shares, such that the total number of authorized shares of the Corporation shall be 1,059,999,330, such shares consisting of 1,000,000,000 shares designated Class A Common Stock, 24,999,330 shares designated LT10 Common Stock, 25,000,000 shares designated LT50 common stock, par value $0.0001 per share, of the Corporation, and 10,000,000 shares designated preferred stock, par value $0.0001 per share, of the Corporation.

Signature page follows.

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Retirement to be signed by its duly authorized officer, this 26th day of April, 2022.


Expensify, Inc.

By:						/s/ Cole Eason
						Cole Eason
						Secretary

CERTIFICATE OF RETIREMENT

830 SHARES OF LT50 COMMON STOCK

EXPENSIFY, INC.

Pursuant to Section 243(b)

of the General Corporation Law

of the State of Delaware

Expensify, Inc., a corporation organized and existing under the General Corporation Law of the State of Delaware (the “DGCL”) (hereinafter the “Corporation”), hereby certifies as follows:

1.830 outstanding shares of LT50 Common Stock, par value $0.0001 per share (“LT50 Common Stock”), of the Corporation have been converted into 830 shares of Class A Common Stock, par value $0.0001 per share (“Class A Common Stock”), of the Corporation.

2.The Amended and Restated Certificate of Incorporation of the Corporation filed with the Secretary of State of the State of Delaware on November 15, 2021 provides that any shares of LT50 Common Stock which are converted into shares of Class A Common Stock shall be retired and may not be reissued by the Corporation.

3.The Board of Directors of the Corporation has adopted resolutions retiring the 830 shares of LT50 Common Stock that converted into 830 shares of Class A Common Stock.

4.Accordingly, pursuant to the provisions of Section 243(b) of the DGCL, upon the filing of this Certificate of Retirement the Amended and Restated Certificate of Incorporation of the Corporation shall be amended so as to reduce the total authorized number of shares of the capital stock of the Corporation by 830 shares, such that the total number of authorized shares of the Corporation shall be 1,059,998,500, such shares consisting of 1,000,000,000 shares designated Class A Common Stock, 24,999,330 shares designated LT10 Common Stock, 24,999,170 shares designated LT50 common stock, par value $0.0001 per share, of the Corporation, and 10,000,000 shares designated preferred stock, par value $0.0001 per share, of the Corporation.

Signature page follows.

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Retirement to be signed by its duly authorized officer, this 27th day of May, 2022.


Expensify, Inc.

By:						/s/ Cole Eason
						Cole Eason
						Secretary

CERTIFICATE OF RETIREMENT

1,769 SHARES OF LT10 COMMON STOCK

EXPENSIFY, INC.

Pursuant to Section 243(b)

of the General Corporation Law

of the State of Delaware

Expensify, Inc., a corporation organized and existing under the General Corporation Law of the State of Delaware (the “DGCL”) (hereinafter the “Corporation”), hereby certifies as follows:

1.1,769 outstanding shares of LT10 Common Stock, par value $0.0001 per share (“LT10 Common Stock”), of the Corporation have been converted into 1,769 shares of Class A Common Stock, par value $0.0001 per share (“Class A Common Stock”), of the Corporation.

3.The Board of Directors of the Corporation has adopted resolutions retiring the 1,769 shares of LT10 Common Stock that converted into 1,769 shares of Class A Common Stock.

4.Accordingly, pursuant to the provisions of Section 243(b) of the DGCL, upon the filing of this Certificate of Retirement the Amended and Restated Certificate of Incorporation of the Corporation shall be amended so as to reduce the total authorized number of shares of the capital stock of the Corporation by 1,769 shares, such that the total number of authorized shares of the Corporation shall be 1,059,996,731, such shares consisting of 1,000,000,000 shares designated Class A Common Stock, 24,997,561 shares designated LT10 Common Stock, 24,999,170 shares designated LT50 common stock, par value $0.0001 per share, of the Corporation, and 10,000,000 shares designated preferred stock, par value $0.0001 per share, of the Corporation.

Signature page follows.

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Retirement to be signed by its duly authorized officer, this 4th day of August, 2022.


Expensify, Inc.

By:						/s/ Cole Eason
						Cole Eason
						Secretary

CERTIFICATE OF RETIREMENT

150 SHARES OF LT50 COMMON STOCK

EXPENSIFY, INC.

Pursuant to Section 243(b)

of the General Corporation Law

of the State of Delaware

Expensify, Inc., a corporation organized and existing under the General Corporation Law of the State of Delaware (the “DGCL”) (hereinafter the “Corporation”), hereby certifies as follows:

1.150 outstanding shares of LT50 Common Stock, par value $0.0001 per share (“LT50 Common Stock”), of the Corporation have been converted into 150 shares of Class A Common Stock, par value $0.0001 per share (“Class A Common Stock”), of the Corporation.

2.The Amended and Restated Certificate of Incorporation of the Corporation filed with the Secretary of State of the State of Delaware on November 15, 2021 provides that any shares of LT50 Common Stock which are converted into shares of Class A Common Stock shall be retired and shall not be reissued by the Corporation.

3.The Board of Directors of the Corporation has adopted resolutions retiring the 150 shares of LT50 Common Stock that converted into 150 shares of Class A Common Stock.

4.Accordingly, pursuant to the provisions of Section 243(b) of the DGCL, upon the filing of this Certificate of Retirement the Amended and Restated Certificate of Incorporation of the Corporation shall be amended so as to reduce the total authorized number of shares of capital stock of the Corporation by 150 shares, such that the total number of authorized shares of the Corporation shall be 1,059,996,581, such shares consisting of 1,000,000,000 shares designated Class A Common Stock, 24,997,561 shares designated LT10 Common Stock, 24,999,020 shares designated LT50 Common Stock, par value of $0.0001 per share, of the Corporation, and 10,000,000 shares designated preferred stock, par value $0.0001 per share, of the Corporation.

Signature page follows.

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Retirement to be signed by its duly authorized officer, this 22nd day of November, 2022.


Expensify, Inc.

By:						/s/ Cole Eason
						Cole Eason
						Secretary

CERTIFICATE OF RETIREMENT

735 SHARES OF LT10 COMMON STOCK

EXPENSIFY, INC.

Pursuant to Section 243(b)

of the General Corporation Law

of the State of Delaware

Expensify, Inc., a corporation organized and existing under the General Corporation Law of the State of Delaware (the “DGCL”) (hereinafter the “Corporation”), hereby certifies as follows:

1.735 outstanding shares of LT10 Common Stock, par value $0.0001 per share (“LT10 Common Stock”), of the Corporation have been converted into 735 shares of Class A Common Stock, par value $0.0001 per share (“Class A Common Stock”), of the Corporation.

3.The Board of Directors of the Corporation has adopted resolutions retiring the 735 shares of LT10 Common Stock that converted into 735 shares of Class A Common Stock.

4.Accordingly, pursuant to the provisions of Section 243(b) of the DGCL, upon the filing of this Certificate of Retirement the Amended and Restated Certificate of Incorporation of the Corporation shall be amended so as to reduce the total authorized number of shares of capital stock of the Corporation by 735 shares, such that the total number of authorized shares of the Corporation shall be 1,059,995,846, such shares consisting of 1,000,000,000 shares designated Class A Common Stock, 24,996,826 shares designated LT10 Common Stock, 24,999,020 shares designated LT50 Common Stock, par value of $0.0001 per share, of the Corporation, and 10,000,000 shares designated preferred stock, par value $0.0001 per share, of the Corporation.

Signature page follows.

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Retirement to be signed by its duly authorized officer, this 8th day of February, 2023.


Expensify, Inc.

By:						/s/ Cole Eason
						Cole Eason
						Secretary

CERTIFICATE OF RETIREMENT

588 SHARES OF LT10 COMMON STOCK

EXPENSIFY, INC.

Pursuant to Section 243(b)

of the General Corporation Law

of the State of Delaware

Expensify, Inc., a corporation organized and existing under the General Corporation Law of the State of Delaware (the “DGCL”) (hereinafter the “Corporation”), hereby certifies as follows:

1.588 outstanding shares of LT10 Common Stock, par value $0.0001 per share (“LT10 Common Stock”), of the Corporation have been converted into 588 shares of Class A Common Stock, par value $0.0001 per share (“Class A Common Stock”), of the Corporation.

3.The Board of Directors of the Corporation has adopted resolutions retiring the 588 shares of LT10 Common Stock that converted into 588 shares of Class A Common Stock.

4.Accordingly, pursuant to the provisions of Section 243(b) of the DGCL, upon the filing of this Certificate of Retirement the Amended and Restated Certificate of Incorporation of the Corporation shall be amended so as to reduce the total authorized number of shares of capital stock of the Corporation by 588 shares, such that the total number of authorized shares of the Corporation shall be 1,059,995,258, such shares consisting of 1,000,000,000 shares designated Class A Common Stock, 24,996,238 shares designated LT10 Common Stock, 24,999,020 shares designated LT50 Common Stock, each with a par value of $0.0001 per share, of the Corporation, and 10,000,000 shares designated preferred stock, par value $0.0001 per share, of the Corporation.

Signature page follows.

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Retirement to be signed by its duly authorized officer, this 23rd day of June, 2023.


Expensify, Inc.

By:						/s/ Cole Eason
						Cole Eason
						Secretary

CERTIFICATE OF RETIREMENT

1,249 SHARES OF LT10 COMMON STOCK

AND

79 SHARES OF LT50 COMMON STOCK

EXPENSIFY, INC.

Pursuant to Section 243(b)

of the General Corporation Law

of the State of Delaware

Expensify, Inc., a corporation organized and existing under the General Corporation Law of the State of Delaware (the “DGCL”) (hereinafter the “Corporation”), hereby certifies as follows:

1.1,249 outstanding shares of LT10 Common Stock, par value $0.0001 per share (“LT10 Common Stock”), of the Corporation have been converted into 1,249 shares of Class A Common Stock, par value $0.0001 per share (“Class A Common Stock”), of the Corporation.

2.79 outstanding shares of LT50 Common Stock, par value $0.0001 per share (“LT50 Common Stock”), of the Corporation have been converted into 79 shares of Class A Common Stock of the Corporation.

3.The Amended and Restated Certificate of Incorporation of the Corporation filed with the Secretary of State of the State of Delaware on November 15, 2021 provides that any shares of LT10 Common Stock or LT50 Common Stock which are converted into shares of Class A Common Stock shall be retired and shall not be reissued by the Corporation.

4.The Board of Directors of the Corporation has adopted resolutions retiring the 1,249 shares of LT10 Common Stock and the 79 shares of LT50 Common Stock that converted into 1,249 and 79 shares of Class A Common Stock, respectively, for a total of 1,328 shares of Class A Common Stock.

5.Accordingly, pursuant to the provisions of Section 243(b) of the DGCL, upon the filing of this Certificate of Retirement, the Amended and Restated Certificate of Incorporation of the Corporation shall be amended so as to reduce the total authorized number of shares of capital stock of the Corporation by 1,328 shares, such that the total number of authorized shares of the Corporation shall be 1,059,993,930, such shares consisting of 1,000,000,000 shares designated Class A Common Stock, 24,994,989 shares designated LT10 Common Stock, 24,998,941 shares designated LT50 Common Stock, each with a par value of $0.0001 per share, of the Corporation, and 10,000,000 shares designated preferred stock, par value $0.0001 per share, of the Corporation.

Signature page follows.

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Retirement to be signed by its duly authorized officer, this 3rd day of August, 2023.


Expensify, Inc.

By:						/s/ Cole Eason
						Cole Eason
						Secretary

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, David Barrett, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Expensify, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ David Barrett

David Barrett

Chief Executive Officer

Date: August 9, 2023

(Principal Executive Officer)

Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Ryan Schaffer, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Expensify, Inc.;

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ Ryan Schaffer

Ryan Schaffer

Chief Financial Officer

Date: August 9, 2023

(Principal Financial Officer)

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Expensify, Inc. (the “Company”) hereby certifies, to such officer’s knowledge, that:

(i) the Quarterly Report on Form 10-Q of the Company for the quarterly period ended June 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ David Barrett

David Barrett

Chief Executive Officer

Date: August 9, 2023

(Principal Executive Officer)

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Ryan Schaffer

Ryan Schaffer

Chief Financial Officer

Date: August 9, 2023

(Principal Financial Officer)

Cover - shares	6 Months Ended
Cover - shares	Jun. 30, 2023	Aug. 04, 2023
Document Information
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2023
Document Transition Report	false
Entity File Number	001-41043
Entity Registrant Name	Expensify, Inc.
Entity Incorporation, State	DE
Entity Tax Identification Number	27-0239450
Entity Address, Street	401 SW 5th Ave
Entity Address, City	Portland
Entity Address, State	OR
Entity Address, Postal Zip Code	97204
City Area Code	971
Local Phone Number	365-3939
Title of each class	Class A Common Stock, par value $0.0001 per share
Trading Symbol(s)	EXFY
Name of each exchange on which registered	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001476840
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Amendment Flag	false
Common Class A
Document Information
Entity Common Stock, Shares Outstanding		68,420,787
Common Stock, LT10
Document Information
Entity Common Stock, Shares Outstanding		7,333,619
Common Stock, LT50
Document Information
Entity Common Stock, Shares Outstanding		7,093,750

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Assets
Cash and cash equivalents	$ 97,795	$ 103,787
Accounts receivable, net	14,922	16,448
Settlement assets, net	39,276	35,838
Prepaid expenses	5,050	8,825
Other current assets	24,606	22,217
Total current assets	181,649	187,115
Capitalized software, net	8,617	6,881
Property and equipment, net	14,545	14,492
Lease right-of-use assets	6,417	745
Deferred tax assets, net	409	344
Other assets	749	664
Total assets	212,386	210,241
Liabilities and stockholders' equity
Accounts payable	1,691	1,059
Accrued expenses and other liabilities	11,650	9,070
Borrowings under line of credit	15,000	15,000
Current portion of long-term debt, net of original issue discount and debt issuance costs	557	551
Lease liabilities, current	278	800
Settlement liabilities	32,500	33,882
Total current liabilities	61,676	60,362
Lease liabilities, non-current	6,226	0
Other liabilities	1,441	1,204
Long-term debt, net of original issue discount and debt issuance costs	43,180	51,434
Total liabilities	112,523	113,000
Commitments and contingencies (Note 4)
Stockholders' equity:
Preferred stock, value, issued	0	0
Common stock issued, value	7	7
Additional paid-in capital	216,422	194,807
Accumulated deficit	(116,566)	(97,573)
Total stockholders' equity	99,863	97,241
Total liabilities and stockholders' equity	$ 212,386	$ 210,241

Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares	Jun. 30, 2023	Dec. 31, 2022
Preferred stock, par value ( in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (shares)	10,000,000	10,000,000
Preferred stock. shares issued (shares)	0	0
Preferred stock, shares outstanding (shares)	0	0
Common Class A
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	68,347,794	68,238,245
Common stock, shares outstanding (in shares)	68,347,794	68,238,245
Common Stock, LT10
Common stock, shares authorized (in shares)	24,996,238	24,997,561
Common stock, shares issued (in shares)	7,334,868	7,336,191
Common stock, shares outstanding (in shares)	7,334,868	7,336,191
Common Stock, LT50
Common stock, shares authorized (in shares)		24,999,020
Common stock, shares issued (in shares)	7,093,829	6,854,931
Common stock, shares outstanding (in shares)	7,093,829	6,854,931

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Revenue	$ 38,884	$ 43,162	$ 78,985	$ 83,532
Cost of revenue, net	16,925	15,876	32,700	30,010
Gross margin	21,959	27,286	46,285	53,522
Operating expenses:
Research and development	5,094	3,584	10,512	7,285
General and administrative	11,712	15,432	24,141	29,438
Sales and marketing	14,714	12,244	23,897	25,616
Total operating expenses	31,520	31,260	58,550	62,339
Loss from operations	(9,561)	(3,974)	(12,265)	(8,817)
Interest and other expenses, net	(1,367)	(1,955)	(2,783)	(2,856)
Loss before income taxes	(10,928)	(5,929)	(15,048)	(11,673)
Provision for income taxes	(376)	(2,065)	(2,201)	(3,697)
Net loss, basic	(11,304)	(7,994)	(17,249)	(15,370)
Net loss, diluted	$ (11,304)	$ (7,994)	$ (17,249)	$ (15,370)
Net loss per share:
Basic (in dollars per share)	$ (0.14)	$ (0.10)	$ (0.21)	$ (0.19)
Diluted (in dollars per share)	$ (0.14)	$ (0.10)	$ (0.21)	$ (0.19)
Weighted average shares of common stock used to compute net loss per share:
Basic (in shares)	82,011,477	80,473,097	81,890,624	80,311,053
Diluted (in shares)	82,011,477	80,473,097	81,890,624	80,311,053

Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity - USD ($) $ in Thousands	Total	Preferred stock	Common stock	Additional paid-in capital	Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2021		0
Beginning balance at Dec. 31, 2021	$ 76,615	$ 0	$ 6	$ 142,515	$ (65,906)
Beginning balance (in shares) at Dec. 31, 2021			81,400,860
Increase (Decrease) in Stockholders' Equity
Issuance of common stock upon exercise of stock options (in shares)			307,075
Issuance of common stock on exercise of stock options	435			435
Vesting of early exercised stock options	751			751
Issuance of restricted stock units (in shares)			6,629
Issuance of restricted stock units	46			46
Repurchases of early exercised stock options (in shares)			(13,070)
Repurchases of early exercised stock options	(20)			(20)
Issuance of common stock under Matching Plan (in shares)			71,522
Issuance of common stock under Matching Plan	1,188			1,188
Stock-based compensation	29,046			29,046
Net loss	(15,370)				(15,370)
Beginning balance (in shares) at Jun. 30, 2022		0
Ending balance at Jun. 30, 2022	92,691	$ 0	$ 6	173,961	(81,276)
Ending balance (in shares) at Jun. 30, 2022			81,773,016
Beginning balance (in shares) at Mar. 31, 2022		0
Beginning balance at Mar. 31, 2022	84,467	$ 0	$ 6	157,743	(73,282)
Beginning balance (in shares) at Mar. 31, 2022			81,606,993
Increase (Decrease) in Stockholders' Equity
Issuance of common stock upon exercise of stock options (in shares)			101,345
Issuance of common stock on exercise of stock options	183			183
Vesting of early exercised stock options	456			456
Issuance of restricted stock units (in shares)			3,896
Issuance of restricted stock units	28			28
Repurchases of early exercised stock options (in shares)			(10,740)
Repurchases of early exercised stock options	(16)			(16)
Issuance of common stock under Matching Plan (in shares)			71,522
Issuance of common stock under Matching Plan	1,188			1,188
Stock-based compensation	14,379			14,379
Net loss	(7,994)				(7,994)
Beginning balance (in shares) at Jun. 30, 2022		0
Ending balance at Jun. 30, 2022	$ 92,691	$ 0	$ 6	173,961	(81,276)
Ending balance (in shares) at Jun. 30, 2022			81,773,016
Beginning balance (in shares) at Dec. 31, 2022	0	0
Beginning balance at Dec. 31, 2022	$ 97,241	$ 0	$ 7	194,807	(97,573)
Beginning balance (in shares) at Dec. 31, 2022			82,429,367
Increase (Decrease) in Stockholders' Equity
Issuance of common stock upon exercise of stock options (in shares)	102,865		102,865
Issuance of common stock on exercise of stock options	$ 125			125
Vesting of early exercised stock options	402			402
Issuance of restricted stock units (in shares)			5,308
Issuance of restricted stock units	61			61
Repurchases of early exercised stock options (in shares)			(1,323)
Repurchases of early exercised stock options	(13)			(13)
Issuance of common stock under Matching Plan (in shares)			441,842
Issuance of common stock under Matching Plan	2,076			2,076
Issuance of common stock in connection with restricted stock units vesting (in shares)			507,153
Shares withheld from common stock issued to pay employee payroll taxes (in shares)			(204,228)
Shares withheld from common stock issued to pay employee payroll taxes	(1,524)			(1,524)
Repurchase and retirement of common stock (in shares)			(504,493)
Repurchase and retirement of common stock	(3,000)			(1,256)	(1,744)
Stock-based compensation	21,744			21,744
Net loss	$ (17,249)				(17,249)
Beginning balance (in shares) at Jun. 30, 2023	0	0
Ending balance at Jun. 30, 2023	$ 99,863	$ 0	$ 7	216,422	(116,566)
Ending balance (in shares) at Jun. 30, 2023			82,776,491
Beginning balance (in shares) at Mar. 31, 2023		0
Beginning balance at Mar. 31, 2023	102,696	$ 0	$ 7	206,207	(103,518)
Beginning balance (in shares) at Mar. 31, 2023			82,806,528
Increase (Decrease) in Stockholders' Equity
Issuance of common stock upon exercise of stock options (in shares)			51,871
Issuance of common stock on exercise of stock options	59			59
Vesting of early exercised stock options	186			186
Issuance of restricted stock units (in shares)			3,760
Issuance of restricted stock units	30			30
Repurchases of early exercised stock options (in shares)			(588)
Repurchases of early exercised stock options	(6)			(6)
Issuance of common stock under Matching Plan (in shares)			278,425
Issuance of common stock under Matching Plan	977			977
Issuance of common stock in connection with restricted stock units vesting (in shares)			261,840
Shares withheld from common stock issued to pay employee payroll taxes (in shares)			(120,852)
Shares withheld from common stock issued to pay employee payroll taxes	(858)			(858)
Repurchase and retirement of common stock (in shares)			(504,493)
Repurchase and retirement of common stock	(3,000)			(1,256)	(1,744)
Stock-based compensation	11,083			11,083
Net loss	$ (11,304)				(11,304)
Beginning balance (in shares) at Jun. 30, 2023	0	0
Ending balance at Jun. 30, 2023	$ 99,863	$ 0	$ 7	$ 216,422	$ (116,566)
Ending balance (in shares) at Jun. 30, 2023			82,776,491

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities:
Net loss	$ (17,249)	$ (15,370)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	2,789	2,735
Reduction of operating lease right-of-use assets	334	358
Loss on impairment, receivables and sale or disposal of equipment	402	475
Stock-based compensation expense	20,345	28,428
Amortization of original issue discount and debt issuance costs	49	21
Deferred tax assets	(65)	(319)
Changes in assets and liabilities:
Accounts receivable, net	1,358	(906)
Settlement assets, net	(5,244)	(8,999)
Prepaid expenses	3,775	2,006
Related party loan receivable	0	14
Other current assets	(952)	1,193
Other assets	(88)	2
Accounts payable	632	(1,583)
Accrued expenses and other liabilities	2,670	(1,366)
Operating lease liabilities	(294)	(404)
Settlement liabilities	(1,382)	19,910
Other liabilities	128	963
Net cash provided by operating activities	7,208	27,158
Cash flows from investing activities:
Purchases of property and equipment	(479)	(267)
Software development costs	(2,043)	(468)
Net cash used in investing activities	(2,522)	(735)
Cash flows from financing activities:
Principal payments of finance leases	(404)	(394)
Principal payments of term loan	(8,300)	(297)
Repurchases of early exercised stock options	(13)	(20)
Proceeds from common stock purchased under Matching Plan	2,076	1,188
Proceeds from issuance of common stock on exercise of stock options	125	519
Payments for employee taxes withheld from stock-based awards	(1,524)	0
Repurchase and retirement of common stock	(3,000)	0
Net cash (used in) provided by financing activities	(11,040)	996
Net (decrease) increase in cash and cash equivalents and restricted cash	(6,354)	27,419
Cash and cash equivalents and restricted cash, beginning of period	147,710	125,315
Cash and cash equivalents and restricted cash, end of period	141,356	152,734
Supplemental disclosure of cash flow information:
Cash paid for interest	2,912	1,750
Cash paid for income taxes	2,251	606
Noncash investing and financing items:
Stock-based compensation capitalized as software development costs	1,399	618
Right-of-use assets acquired through operating leases	6,402	0
Accrued property and equipment	373	0
Reconciliation of cash and cash equivalents and restricted cash to the Condensed Consolidated Balance Sheets
Cash and cash equivalents	97,795	105,537
Restricted cash included in other current assets	20,986	16,077
Restricted cash included in settlement assets, net	22,575	31,120
Total cash, cash equivalents and restricted cash	$ 141,356	$ 152,734

GENERAL INFORMATION	6 Months Ended
GENERAL INFORMATION	Jun. 30, 2023
Accounting Policies [Abstract]
GENERAL INFORMATION	GENERAL INFORMATION Description of the Business Expensify, Inc. ("Expensify") was incorporated in Delaware on April 29, 2009. Expensify offers a comprehensive expense management platform that integrates with a variety of third-party accounting applications, including QuickBooks Desktop, QuickBooks Online, Xero, NetSuite, Intacct, Sage, Microsoft Dynamics, MYOB and others. Expensify's product simplifies the way that employees and vendors manage and submit expense receipts and bills and provides efficiencies to companies for the payment of those bills. Expensify delivers its services over the internet to corporations and individuals under license arrangements and offers unique pricing options for small and midsized businesses and enterprises on a per-active-member basis. Expensify also offers an Expensify charge card (the "Expensify Card"), which is primarily distributed to corporate customers in the United States ("U.S.") that subsequently distribute the card to their employees for business use. The Expensify Card allows customers to have real-time control over their employees' spending and compliance with spending limits in addition to eReceipt reporting on purchases. Basis of Presentation and Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of Expensify and its wholly-owned subsidiaries (the "Company") and have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") and the applicable rules and regulations of the Securities and Exchange Commission ("SEC") for interim reporting in conformity with the instructions to Form 10-Q and Article 10 of Regulation S-X. Certain information and footnote disclosures normally included in financial statements presented in accordance with GAAP have been condensed or omitted pursuant to such SEC rules. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report on Form 10-K for the year ended December 31, 2022 ("2022 Annual Report"). All intercompany transactions and balances have been eliminated in consolidation. In the opinion of management, the accompanying condensed consolidated financial statements reflect all normal and recurring adjustments that are necessary for the fair presentation of the Company's financial position, results of operations, equity, and cash flows for the periods presented. Results of operations for the three and six months ended June 30, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023 or for any other future annual or interim period. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates and judgments are based on historical experience, forecasted events and various other assumptions that the Company believes to be reasonable under the circumstances. Estimates and judgments are evaluated on an ongoing basis. Actual results could differ from those estimates. Changes in estimates are recorded in the period in which they become known. Significant estimates and assumptions by management affect the Company’s classification of employee and employee-related expenses, the useful lives and recoverability of long-lived assets, income taxes, capitalization of internal-use software costs, stock-based compensation and the Company's incremental borrowing rate (IBR) utilized to measure its operating lease assets and lease liabilities. Updates to Significant Accounting Policies The Company’s significant accounting policies are discussed in Note 2 of the 2022 Annual Report. Since the date the 2022 Annual Report was filed with the SEC, there have been no material changes to the Company's significant accounting policies, including the status of recent accounting pronouncements adopted, other than those detailed below. Recently Adopted Accounting Pronouncements In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments, with subsequent ASUs issued that clarify the guidance (collectively, "Topic 326"). Topic 326 requires an entity to utilize a new impairment model known as the current expected credit loss ("CECL") model to estimate its “lifetime expected credit losses" using a forward-looking approach and to record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The CECL model is expected to result in more timely recognition of credit losses. Topic 326 also requires new disclosures for financial assets measured at amortized cost, loans and available-for-sale debt securities. As a result of no longer qualifying as an emerging growth company as of December 31, 2022, the Company was required to adopt Topic 326 retroactive to January 1, 2022. The Company was not required to amend quarterly filings issued subsequent to January 1, 2022 in which the Company filed under the legacy credit loss guidance of Accounting Standards Codification ("ASC") Topic 310. As such, the 2022 Annual Report was the first period under which the Company reported credit loss estimates in accordance with Topic 326. The adoption of Topic 326 did not have a material impact on the Company's financial position or results of operations as of and for the three and six months ended June 30, 2022.

REVENUE AND CERTAIN STATEMENTS OF OPERATIONS COMPONENTS

6 Months Ended

Jun. 30, 2023

Revenue Recognition and Deferred Revenue [Abstract]

REVENUE AND CERTAIN STATEMENT OF OPERATIONS COMPONENTS

Revenue by geographic region, based on user address, was as follows (in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
United States	$	35,487	$	39,388	$	72,122	$	75,906
All other locations	3,397		3,774		6,863		7,626
Total revenue	$	38,884	$	43,162	$	78,985	$	83,532

No individual customer represented more than 10% of the Company’s total revenue during the three and six months ended June 30, 2023 and 2022.

Cashback Rewards

Consideration From a Vendor, Net The Company receives consideration from a vendor for monetizing Expensify Card activities. This consideration, net of credit card processing fees paid to the vendor, is included as a reduction to Cost of revenue, net within the Condensed Consolidated Statements of Operations. Consideration from a vendor, net for the three months ended June 30, 2023 and 2022 was $2.4 million and $1.5 million, respectively. Consideration from a vendor, net for the six months ended June 30, 2023 and 2022 was $4.5 million and $2.7 million, respectively

CERTAIN BALANCE SHEET COMPONENTS

6 Months Ended

Jun. 30, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

CERTAIN BALANCE SHEET COMPONENTS

Other Current Assets

Other current assets consisted of the following (in thousands):


	As of June 30,		As of December 31,
	2023		2022
Expensify Card posted collateral for funds held for customers	$	9,024	$	11,509
Cash in transit for funds held for customers	6,088		2,361
Expensify.org restricted cash	5,721		5,518
Income tax receivable	3,325		2,471
Expensify Payments LLC restricted cash	99		102
Matching Plan escrow and other restricted cash	54		52
Deferred contract acquisition costs	53		—
Other	242		204
Other current assets	$	24,606	$	22,217

Capitalized Software, Net

Capitalized software, net consisted of the following (in thousands):


	As of June 30,		As of December 31,
	2023		2022
Capitalized software development costs	$	17,139	$	14,052
Less: accumulated amortization	(8,522)		(7,171)
Capitalized software, net	$	8,617	$	6,881

Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):


	As of June 30,		As of December 31,
	2023		2022
Computers and equipment	$	178	$	178
Furniture and fixtures	1,855		1,698
Leasehold improvements	6,957		6,948
Commercial building	6,493		6,493
Land	4,151		4,151
Construction in progress	3,339		2,551
Total property and equipment	22,973		22,019
Less: accumulated depreciation	(8,428)		(7,527)
Property and equipment, net	$	14,545	$	14,492

Accrued Expenses and Other Liabilities

Accrued expenses and other liabilities consisted of the following (in thousands):


	As of June 30,		As of December 31,
	2023		2022
Sales, payroll and other taxes payable	$	3,254	$	2,721
Professional fees	2,704		1,473
Partner payouts and advertising fees	1,444		669
Interest payable	1,389		1,318
Restricted common stock liability for early stock option exercises	881		1,283
Cashback rewards	524		223
Matching Plan payroll liability	183		195
Accrued expense reports	168		291
Commissions payable	135		—
Hosting and license fees	85		75
Credit card processing fees	41		22
Other	842		800
Accrued expenses and other liabilities	$	11,650	$	9,070

COMMITMENTS AND CONTINGENCIES

6 Months Ended

Jun. 30, 2023

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

Finance and Operating Lease Arrangements


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Finance lease cost:
Amortization of ROU assets	$	197	$	198	$	395	$	395
Interest on lease liabilities	1		6		4		14
Total finance lease cost	198		204		399		409
Operating lease cost	244		173		430		358
Total lease cost	$	442	$	377	$	829	$	767

Other information related to leases was as follows (in thousands, except as noted within):


	As of June 30,			As of December 31,
	2023			2022
Finance lease ROU asset (included within Lease right-of-use assets)	$	66		$	461
Operating lease ROU asset (included within Lease right-of-use assets)	$	6,351		$	284
Weighted average remaining lease term (in years):
Finance leases	0.08			0.58
Operating leases	9.61			0.42
Weighted average discount rate:
Finance leases	2.50		%	2.50		%
Operating leases	8.30		%	5.30		%

Supplemental cash flow information related to leases was as follows (in thousands):


	Six months ended June 30,
	2023		2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	(322)	$	(399)
Operating cash flows from finance leases	$	(4)	$	(14)
Financing cash flows from finance leases	$	(404)	$	(394)

Maturities of lease liabilities as of June 30, 2023 were as follows (in thousands):


For the year ending:	Finance leases		Operating leases
Remainder of 2023	$	68	$	176
2024	—		838
2025	—		1,079
2026	—		1,018
2027	—		1,033
Thereafter	—		5,562
Total future lease payments	68		9,706
Less: imputed interest	—		(3,270)
Less: Lease liabilities, current	(68)		(210)
Lease liabilities, non-current	$	—	$	6,226

Amortizing Term Mortgage

2021 Amended Term Loan

Monthly Revolving Line of Credit

Future aggregate annual principal payments on long-term debt as of June 30, 2023 is expected to be as follows (in thousands):


For the year ending:
Remainder of 2023	$	297
2024	715
2025	1,398
2026	34,356
2027	176
Thereafter	7,014
Total principal payments	43,956
Less: unamortized original issue discount and debt issuance costs	(219)
Less: Current portion of long-term debt, net of unamortized original issue discount and debt issuance costs	(557)
Long-term debt, net of unamortized original issue discount and debt issuance costs	$	43,180

Defined Contribution Plans

Legal

STOCK INCENTIVE PLANS

6 Months Ended

Jun. 30, 2023

Share-Based Payment Arrangement [Abstract]

STOCK INCENTIVE PLANS

2009 and 2019 Stock Plans

2021 Incentive Plans

Matching Plan

Restricted Stock Units

During the six months ended June 30, 2023, RSU activity for Service Providers and non-employee directors was as follows:


	Class A Common Stock	LT50 Common Stock	Weighted average grant date fair value per share
Outstanding at December 31, 2022	3,379,657	3,304,643	$	33.88
RSUs granted	55,731	—	$	8.17
RSUs vested	(266,381)	(238,898)	$	32.65
RSUs cancelled/forfeited/expired	(100,709)	(100,709)	$	40.92
Outstanding at June 30, 2023	3,068,298	2,965,036	$	33.71

Stock Options

A summary of the Company's stock option activity was as follows:


	Shares	Weighted average exercise price per share		Weighted average remaining contractual life (in years)
Outstanding at December 31, 2022	6,301,650	$	1.67	5.20
Options exercised	(102,865)	$	1.21
Options cancelled/forfeited/expired	(44,789)	$	3.40
Outstanding at June 30, 2023	6,153,996	$	1.66	4.63
Exercisable at June 30, 2023	6,024,296	$	1.46	4.59

Cash received from option exercises and purchases of shares under the Stock Plans for the six months ended June 30, 2023 and 2022 was $0.1 million and $0.5 million, respectively.

Stock-Based Compensation


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Matching Plan shares	$	1,072	$	15	$	1,321	$	17
Stock options	874		993		1,774		1,999
Restricted stock units	9,137		13,040		18,649		26,412
Stock-based compensation	$	11,083	$	14,048	$	21,744	$	28,428


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Cost of revenue, net	$	3,600	$	4,704	$	6,906	$	9,611
Research and development	2,455		1,877		4,661		4,298
General and administrative	2,376		5,463		5,020		10,439
Sales and marketing	1,910		2,004		3,758		4,080
Stock-based compensation expense	$	10,341	$	14,048	$	20,345	$	28,428

INCOME TAXES	6 Months Ended
INCOME TAXES	Jun. 30, 2023
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES For the three and six months ended June 30, 2023, the Company prepared its interim tax provision by applying a year-to-date effective tax rate, which the Company believes results in the best estimate of the annual effective tax rate. For the three months ended June 30, 2023 and 2022, the Company recorded a provision for income taxes of $0.4 million and $2.1 million, respectively, which resulted in effective tax rates of (3.4)% and (34.8)%, respectively. For the six months ended June 30, 2023 and 2022, the Company recorded a provision for income taxes of $2.2 million and $3.7 million, respectively, which resulted in effective tax rates of (14.6)% and (31.7)%, respectively. The principal reasons for the difference between the statutory rate and the effective rate for 2023 were primarily due to non-deductible stock-based compensation, Section 162(m) of the Internal Revenue Code ("IRC") compensation limitations, and the change in the valuation allowance. The principal reasons for the difference between the statutory rate and the effective rate for 2022 was due to the change in valuation allowance. The Company follows the provisions of ASC 740-10, Accounting for Uncertainty in Income Taxes. ASC 740-10 prescribes a comprehensive model for the recognition, measurement, presentation and disclosure in financial statements of uncertain tax positions that have been taken or expected to be taken on a tax return. As of June 30, 2023 and December 31, 2022, the Company recorded an uncertain tax position liability, inclusive of interest and penalties, of $1.3 million and $1.2 million respectively, within Other liabilities on the Condensed Consolidated Balance Sheets. This liability includes an immaterial amount of interest and penalties as of June 30, 2023 and no interest and penalties as of December 31, 2022.

NET LOSS PER SHARE

6 Months Ended

Jun. 30, 2023

Earnings Per Share [Abstract]

NET LOSS PER SHARE

The following table sets forth the computation of basic and diluted net loss per share (in thousands, except share and per share data):


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Numerator
Net loss, basic and diluted	$	(11,304)	$	(7,994)	$	(17,249)	$	(15,370)
Denominator
Weighted average shares of common stock used to compute net loss per share, basic and diluted	82,011,477		80,473,097		81,890,624		80,311,053
Net loss per share, basic and diluted	$	(0.14)	$	(0.10)	$	(0.21)	$	(0.19)

The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive:


	Three Months Ended June 30,		Six Months Ended June 30,
	2023	2022	2023	2022
Weighted-average stock options	4,061,602	5,418,741	4,213,114	6,065,482
Matching shares	247	6,220	352	6,748
Total	4,061,849	5,424,961	4,213,466	6,072,230

EQUITY	6 Months Ended
EQUITY	Jun. 30, 2023
Equity [Abstract]
EQUITY	EQUITYOn May 10, 2022, the Executive Committee of the Board of Directors approved a share repurchase program with authorization to purchase up to $50.0 million of shares of Class A common stock ("2022 Share Repurchase Program"). The Company may repurchase shares from time to time through open market purchases, in privately negotiated transactions or by other means, including the use of trading plans intended to qualify under Rule 10b5-1 of the Securities Exchange Act of 1934 ("Exchange Act"), in accordance with applicable securities laws and other restrictions. The actual timing, manner, price and total amount of future repurchases will depend on a variety of factors, including business, economic and market conditions, corporate and regulatory requirements, prevailing stock prices, restrictions under the terms of loan agreements and other considerations. The 2022 Share Repurchase Program does not obligate the Company to acquire any particular amount of Class A common stock, and the program may be suspended or terminated at any time by the Company at its discretion without prior notice. During the three and six months ended June 30, 2023, the Company repurchased 504,493 shares of Class A common stock under the 2022 Share Repurchase Program, at a total cost to the Company of $3.0 million.

RELATED PARTY TRANSACTIONS	6 Months Ended
RELATED PARTY TRANSACTIONS	Jun. 30, 2023
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	RELATED PARTY TRANSACTIONSDuring the six months ended June 30, 2023 and 2022, Expensify, Inc. contributed $0.2 million and $1.9 million, respectively, to its wholly-owned subsidiary, Expensify.org, a nonprofit benefit organization established by the Company. There was an immaterial amount of commitments from Expensify, Inc. that remained open for contribution as of June 30, 2023 and December 31, 2022. There are no other significant related party transactions for the Company as of June 30, 2023, except as noted elsewhere in these condensed consolidated financial statements.

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Pay vs Performance Disclosure
Net loss	$ (11,304)	$ (7,994)	$ (17,249)	$ (15,370)

GENERAL INFORMATION (Policies)	6 Months Ended
GENERAL INFORMATION (Policies)	Jun. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of Expensify and its wholly-owned subsidiaries (the "Company") and have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") and the applicable rules and regulations of the Securities and Exchange Commission ("SEC") for interim reporting in conformity with the instructions to Form 10-Q and Article 10 of Regulation S-X. Certain information and footnote disclosures normally included in financial statements presented in accordance with GAAP have been condensed or omitted pursuant to such SEC rules. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report on Form 10-K for the year ended December 31, 2022 ("2022 Annual Report"). All intercompany transactions and balances have been eliminated in consolidation. In the opinion of management, the accompanying condensed consolidated financial statements reflect all normal and recurring adjustments that are necessary for the fair presentation of the Company's financial position, results of operations, equity, and cash flows for the periods presented.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates and judgments are based on historical experience, forecasted events and various other assumptions that the Company believes to be reasonable under the circumstances. Estimates and judgments are evaluated on an ongoing basis. Actual results could differ from those estimates. Changes in estimates are recorded in the period in which they become known. Significant estimates and assumptions by management affect the Company’s classification of employee and employee-related expenses, the useful lives and recoverability of long-lived assets, income taxes, capitalization of internal-use software costs, stock-based compensation and the Company's incremental borrowing rate (IBR) utilized to measure its operating lease assets and lease liabilities.
Recent Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments, with subsequent ASUs issued that clarify the guidance (collectively, "Topic 326"). Topic 326 requires an entity to utilize a new impairment model known as the current expected credit loss ("CECL") model to estimate its “lifetime expected credit losses" using a forward-looking approach and to record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The CECL model is expected to result in more timely recognition of credit losses. Topic 326 also requires new disclosures for financial assets measured at amortized cost, loans and available-for-sale debt securities. As a result of no longer qualifying as an emerging growth company as of December 31, 2022, the Company was required to adopt Topic 326 retroactive to January 1, 2022. The Company was not required to amend quarterly filings issued subsequent to January 1, 2022 in which the Company filed under the legacy credit loss guidance of Accounting Standards Codification ("ASC") Topic 310. As such, the 2022 Annual Report was the first period under which the Company reported credit loss estimates in accordance with Topic 326. The adoption of Topic 326 did not have a material impact on the Company's financial position or results of operations as of and for the three and six months ended June 30, 2022.

REVENUE AND CERTAIN STATEMENTS OF OPERATIONS COMPONENTS (Tables)

6 Months Ended

Jun. 30, 2023

Revenue Recognition and Deferred Revenue [Abstract]

Schedule of Revenue from Geographic Areas

Revenue by geographic region, based on user address, was as follows (in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
United States	$	35,487	$	39,388	$	72,122	$	75,906
All other locations	3,397		3,774		6,863		7,626
Total revenue	$	38,884	$	43,162	$	78,985	$	83,532

CERTAIN BALANCE SHEET COMPONENTS (Tables)

6 Months Ended

Jun. 30, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Other Current Assets

Other current assets consisted of the following (in thousands):


	As of June 30,		As of December 31,
	2023		2022
Expensify Card posted collateral for funds held for customers	$	9,024	$	11,509
Cash in transit for funds held for customers	6,088		2,361
Expensify.org restricted cash	5,721		5,518
Income tax receivable	3,325		2,471
Expensify Payments LLC restricted cash	99		102
Matching Plan escrow and other restricted cash	54		52
Deferred contract acquisition costs	53		—
Other	242		204
Other current assets	$	24,606	$	22,217

Schedule of Capitalized Software, Net

Capitalized software, net consisted of the following (in thousands):


	As of June 30,		As of December 31,
	2023		2022
Capitalized software development costs	$	17,139	$	14,052
Less: accumulated amortization	(8,522)		(7,171)
Capitalized software, net	$	8,617	$	6,881

Schedule of Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):


	As of June 30,		As of December 31,
	2023		2022
Computers and equipment	$	178	$	178
Furniture and fixtures	1,855		1,698
Leasehold improvements	6,957		6,948
Commercial building	6,493		6,493
Land	4,151		4,151
Construction in progress	3,339		2,551
Total property and equipment	22,973		22,019
Less: accumulated depreciation	(8,428)		(7,527)
Property and equipment, net	$	14,545	$	14,492

Schedule of Accrued Expenses and Other Liabilities

Accrued expenses and other liabilities consisted of the following (in thousands):


	As of June 30,		As of December 31,
	2023		2022
Sales, payroll and other taxes payable	$	3,254	$	2,721
Professional fees	2,704		1,473
Partner payouts and advertising fees	1,444		669
Interest payable	1,389		1,318
Restricted common stock liability for early stock option exercises	881		1,283
Cashback rewards	524		223
Matching Plan payroll liability	183		195
Accrued expense reports	168		291
Commissions payable	135		—
Hosting and license fees	85		75
Credit card processing fees	41		22
Other	842		800
Accrued expenses and other liabilities	$	11,650	$	9,070

COMMITMENTS AND CONTINGENCIES (Tables)

6 Months Ended

Jun. 30, 2023

Commitments and Contingencies Disclosure [Abstract]

Schedule of Lease Cost

The components of lease cost reflected in the Condensed Consolidated Statements of Operations for all leases were as follows (in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Finance lease cost:
Amortization of ROU assets	$	197	$	198	$	395	$	395
Interest on lease liabilities	1		6		4		14
Total finance lease cost	198		204		399		409
Operating lease cost	244		173		430		358
Total lease cost	$	442	$	377	$	829	$	767

Supplemental cash flow information related to leases was as follows (in thousands):


	Six months ended June 30,
	2023		2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	(322)	$	(399)
Operating cash flows from finance leases	$	(4)	$	(14)
Financing cash flows from finance leases	$	(404)	$	(394)

Schedule of Supplemental Balance Sheet Information

Other information related to leases was as follows (in thousands, except as noted within):


	As of June 30,			As of December 31,
	2023			2022
Finance lease ROU asset (included within Lease right-of-use assets)	$	66		$	461
Operating lease ROU asset (included within Lease right-of-use assets)	$	6,351		$	284
Weighted average remaining lease term (in years):
Finance leases	0.08			0.58
Operating leases	9.61			0.42
Weighted average discount rate:
Finance leases	2.50		%	2.50		%
Operating leases	8.30		%	5.30		%

Schedule of Finance Lease Maturity

Maturities of lease liabilities as of June 30, 2023 were as follows (in thousands):


For the year ending:	Finance leases		Operating leases
Remainder of 2023	$	68	$	176
2024	—		838
2025	—		1,079
2026	—		1,018
2027	—		1,033
Thereafter	—		5,562
Total future lease payments	68		9,706
Less: imputed interest	—		(3,270)
Less: Lease liabilities, current	(68)		(210)
Lease liabilities, non-current	$	—	$	6,226

Schedule of Operating Lease Maturity

Maturities of lease liabilities as of June 30, 2023 were as follows (in thousands):


For the year ending:	Finance leases		Operating leases
Remainder of 2023	$	68	$	176
2024	—		838
2025	—		1,079
2026	—		1,018
2027	—		1,033
Thereafter	—		5,562
Total future lease payments	68		9,706
Less: imputed interest	—		(3,270)
Less: Lease liabilities, current	(68)		(210)
Lease liabilities, non-current	$	—	$	6,226

Summary of Principal Payments on all Long-term Debt

Future aggregate annual principal payments on long-term debt as of June 30, 2023 is expected to be as follows (in thousands):


For the year ending:
Remainder of 2023	$	297
2024	715
2025	1,398
2026	34,356
2027	176
Thereafter	7,014
Total principal payments	43,956
Less: unamortized original issue discount and debt issuance costs	(219)
Less: Current portion of long-term debt, net of unamortized original issue discount and debt issuance costs	(557)
Long-term debt, net of unamortized original issue discount and debt issuance costs	$	43,180

STOCK INCENTIVE PLANS (Tables)

6 Months Ended

Jun. 30, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of RSU Rollforward

During the six months ended June 30, 2023, RSU activity for Service Providers and non-employee directors was as follows:


	Class A Common Stock	LT50 Common Stock	Weighted average grant date fair value per share
Outstanding at December 31, 2022	3,379,657	3,304,643	$	33.88
RSUs granted	55,731	—	$	8.17
RSUs vested	(266,381)	(238,898)	$	32.65
RSUs cancelled/forfeited/expired	(100,709)	(100,709)	$	40.92
Outstanding at June 30, 2023	3,068,298	2,965,036	$	33.71

Schedule of Stock Option Roll-forward

A summary of the Company's stock option activity was as follows:


	Shares	Weighted average exercise price per share		Weighted average remaining contractual life (in years)
Outstanding at December 31, 2022	6,301,650	$	1.67	5.20
Options exercised	(102,865)	$	1.21
Options cancelled/forfeited/expired	(44,789)	$	3.40
Outstanding at June 30, 2023	6,153,996	$	1.66	4.63
Exercisable at June 30, 2023	6,024,296	$	1.46	4.59

Schedule of Stock-based Compensation Expense


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Matching Plan shares	$	1,072	$	15	$	1,321	$	17
Stock options	874		993		1,774		1,999
Restricted stock units	9,137		13,040		18,649		26,412
Stock-based compensation	$	11,083	$	14,048	$	21,744	$	28,428


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Cost of revenue, net	$	3,600	$	4,704	$	6,906	$	9,611
Research and development	2,455		1,877		4,661		4,298
General and administrative	2,376		5,463		5,020		10,439
Sales and marketing	1,910		2,004		3,758		4,080
Stock-based compensation expense	$	10,341	$	14,048	$	20,345	$	28,428

NET LOSS PER SHARE (Tables)

6 Months Ended

Jun. 30, 2023

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth the computation of basic and diluted net loss per share (in thousands, except share and per share data):


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Numerator
Net loss, basic and diluted	$	(11,304)	$	(7,994)	$	(17,249)	$	(15,370)
Denominator
Weighted average shares of common stock used to compute net loss per share, basic and diluted	82,011,477		80,473,097		81,890,624		80,311,053
Net loss per share, basic and diluted	$	(0.14)	$	(0.10)	$	(0.21)	$	(0.19)

Schedule of Anti-dilutive Securities

The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive:


	Three Months Ended June 30,		Six Months Ended June 30,
	2023	2022	2023	2022
Weighted-average stock options	4,061,602	5,418,741	4,213,114	6,065,482
Matching shares	247	6,220	352	6,748
Total	4,061,849	5,424,961	4,213,466	6,072,230

REVENUE AND CERTAIN STATEMENTS OF OPERATIONS COMPONENTS - Total Revenue by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Disaggregation of Revenue
Revenue	$ 38,884	$ 43,162	$ 78,985	$ 83,532
United States
Disaggregation of Revenue
Revenue	35,487	39,388	72,122	75,906
All other locations
Disaggregation of Revenue
Revenue	$ 3,397	$ 3,774	$ 6,863	$ 7,626

REVENUE AND CERTAIN STATEMENTS OF OPERATIONS COMPONENTS - Narratives (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Disaggregation of Revenue
Consideration from a vendor, net	$ 2.4	$ 1.5	$ 4.5	$ 2.7
Cashback rewards
Disaggregation of Revenue
Cashback rewards	$ 1.8	$ 0.7	$ 3.0	$ 1.2

CERTAIN BALANCE SHEET COMPONENTS - Other current assets (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Schedule Of Other Current Assets
Expensify Card posted collateral for funds held for customers	$ 9,024	$ 11,509
Cash in transit for funds held for customers	6,088	2,361
Income tax receivable	3,325	2,471
Matching Plan escrow and other restricted cash	54	52
Deferred contract acquisition costs	53
Deferred contract acquisition costs		0
Other	242	204
Other current assets	24,606	22,217
Expensify Payment LLC \| Affiliated Entity
Schedule Of Other Current Assets
Restricted cash	99	102
Subsidiaries \| Expensify.Org
Schedule Of Other Current Assets
Restricted cash	$ 5,721	$ 5,518

CERTAIN BALANCE SHEET COMPONENTS - Capitalized software, net (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Capitalized software development costs	$ 17,139	$ 14,052
Less: accumulated amortization	(8,522)	(7,171)
Capitalized software, net	$ 8,617	$ 6,881

CERTAIN BALANCE SHEET COMPONENTS - Narratives (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Amortization expense	$ 0.8	$ 0.7	$ 1.5	$ 1.3
Depreciation	$ 0.4	$ 0.5	$ 0.9	$ 1.0

CERTAIN BALANCE SHEET COMPONENTS - Property and equipment, net (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Property, Plant and Equipment
Total property and equipment	$ 22,973	$ 22,019
Less: accumulated depreciation	(8,428)	(7,527)
Property and equipment, net	14,545	14,492
Computers and equipment
Property, Plant and Equipment
Total property and equipment	178	178
Furniture and fixtures
Property, Plant and Equipment
Total property and equipment	1,855	1,698
Leasehold improvements
Property, Plant and Equipment
Total property and equipment	6,957	6,948
Commercial building
Property, Plant and Equipment
Total property and equipment	6,493	6,493
Land
Property, Plant and Equipment
Total property and equipment	4,151	4,151
Construction in progress
Property, Plant and Equipment
Total property and equipment	$ 3,339	$ 2,551

CERTAIN BALANCE SHEET COMPONENTS - Accrued expenses and other liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Sales, payroll and other taxes payable	$ 3,254	$ 2,721
Professional fees	2,704	1,473
Partner payouts and advertising fees	1,444	669
Interest payable	1,389	1,318
Restricted common stock liability for early stock option exercises	881	1,283
Cashback rewards	524	223
Matching Plan payroll liability	183	195
Accrued expense reports	168	291
Commissions payable	135	0
Hosting and license fees	85	75
Credit card processing fees	41	22
Other	842	800
Accrued expenses and other liabilities	$ 11,650	$ 9,070

COMMITMENTS AND CONTINGENCIES - Narratives (Details)	Jun. 30, 2023 lease
Commitments and Contingencies Disclosure [Abstract]
Number of operating lease agreements (lease)	4

COMMITMENTS AND CONTINGENCIES - Summary of Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Finance lease cost:
Amortization of ROU assets	$ 197	$ 198	$ 395	$ 395
Interest on lease liabilities	1	6	4	14
Total finance lease cost	198	204	399	409
Operating lease cost	244	173	430	358
Total lease cost	$ 442	$ 377	$ 829	$ 767

COMMITMENTS AND CONTINGENCIES - Summary of Related to Leases (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Finance lease ROU asset (included within Lease right-of-use assets)	$ 66	$ 461
Operating lease ROU asset (included within Lease right-of-use assets)	$ 6,351	$ 284
Weighted average remaining lease term (in years):
Finance leases	29 days	6 months 29 days
Operating leases	9 years 7 months 9 days	5 months 1 day
Weighted average discount rate:
Finance leases	2.50%	2.50%
Operating leases	8.30%	5.30%
Finance Lease, Right-of-Use Asset, Statement of Financial Position	Lease right-of-use assets	Lease right-of-use assets
Operating Lease, Right-of-Use Asset, Statement of Financial Position	Lease right-of-use assets	Lease right-of-use assets

COMMITMENTS AND CONTINGENCIES - Cashflow Disclosures (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ (322)	$ (399)
Operating cash flows from finance leases	(4)	(14)
Financing cash flows from finance leases	$ (404)	$ (394)

COMMITMENTS AND CONTINGENCIES - Lease Maturity Schedule (Details) $ in Thousands	Jun. 30, 2023 USD ($)
Finance leases
Remainder of 2023	$ 68
2024	0
2025	0
2026	0
2027	0
Thereafter	0
Total future lease payments	68
Less: imputed interest	0
Less: Lease liabilities, current	(68)
Lease liabilities, non-current	$ 0
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Lease Liability, Current
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Lease liabilities, non-current
Operating leases
Remainder of 2023	$ 176
2024	838
2025	1,079
2026	1,018
2027	1,033
Thereafter	5,562
Total future lease payments	9,706
Less: imputed interest	(3,270)
Less: Lease liabilities, current	(210)
Lease liabilities, non-current	$ 6,226
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Lease liabilities, current
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Lease liabilities, non-current

COMMITMENTS AND CONTINGENCIES - Amortizing Term Mortgage Narratives (Details) - USD ($) $ in Thousands	1 Months Ended
	Aug. 31, 2019	Jun. 30, 2023	Dec. 31, 2022
Schedule of Capitalization, Long-term Debt
Long-term debt, net of original issue discount and debt issuance costs		$ 43,180	$ 51,434
Mortgages
Schedule of Capitalization, Long-term Debt
Loaned amount	$ 8,300
Debt instrument, term (in years)	30 years
Interest rate (as a percent)	5.00%
Long-term debt, net of original issue discount and debt issuance costs		$ 7,800	$ 7,800
Mortgages \| Prime Rate
Schedule of Capitalization, Long-term Debt
Variable rate (as a percent)	0.25%

COMMITMENTS AND CONTINGENCIES - 2021 Amended Term Loan Narratives (Details) - USD ($)					1 Months Ended	3 Months Ended	6 Months Ended
	Oct. 01, 2025	Oct. 01, 2024	Sep. 30, 2024	Sep. 30, 2021	Sep. 30, 2021	Jun. 30, 2023	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Schedule of Capitalization, Long-term Debt
Repayments of long term debt							$ 8,300,000	$ 297,000
Long-term debt, net of original issue discount and debt issuance costs						$ 43,180,000	$ 43,180,000		$ 51,434,000
2021 Amended Term Loan \| Secured Debt
Schedule of Capitalization, Long-term Debt
Maximum borrowing capacity				$ 75,000,000	$ 75,000,000
Repayments of long term debt						8,000,000
Loss on extinguishment of debt						$ 0
Effective interest rate (as a percent)						10.50%	10.50%
Long-term debt, net of original issue discount and debt issuance costs						$ 36,200,000	$ 36,200,000		$ 44,500,000
2021 Amended Term Loan \| Secured Debt \| Reference Rate
Schedule of Capitalization, Long-term Debt
Variable rate (as a percent)				2.25%
2021 Amended Term Loan \| Secured Debt \| Forecast \| Subsequent Event
Schedule of Capitalization, Long-term Debt
Periodic payment	$ 600,000	$ 200,000	$ 100,000
2021 Amended Term Loan \| Line of Credit \| Revolving Credit Facility
Schedule of Capitalization, Long-term Debt
Maximum borrowing capacity				$ 25,000,000	25,000,000	$ 25,000,000	$ 25,000,000
Repayments of long term debt					23,500,000
2021 Amended Term Loan \| Line of Credit \| Revolving Credit Facility \| Reference Rate
Schedule of Capitalization, Long-term Debt
Variable rate (as a percent)							1.00%
Effective interest rate (as a percent)						9.25%	9.25%
Initial Term Loan \| Secured Debt
Schedule of Capitalization, Long-term Debt
Maximum borrowing capacity				45,000,000	$ 45,000,000
Debt instrument, term (in years)					60 months
Delayed Term Loan \| Secured Debt
Schedule of Capitalization, Long-term Debt
Maximum borrowing capacity				$ 30,000,000	$ 30,000,000

COMMITMENTS AND CONTINGENCIES - Monthly revolving line of credit Narratives (Details) - USD ($)	6 Months Ended
	Jun. 30, 2023	Dec. 31, 2022	Sep. 30, 2021
Line of Credit Facility
Borrowings under line of credit	$ 15,000,000	$ 15,000,000
Unamortized debt issuance cost	219,000	300,000
2021 Amended Term Loan
Line of Credit Facility
Debt issuance cost	0
Issuance discount	0
Revolving Credit Facility \| 2021 Amended Term Loan \| Line of Credit
Line of Credit Facility
Maximum borrowing capacity	25,000,000		$ 25,000,000
Borrowings under line of credit	15,000,000	15,000,000
Remaining borrowing capacity	$ 10,000,000	$ 10,000,000
Revolving Credit Facility \| 2021 Amended Term Loan \| Line of Credit \| Reference Rate
Line of Credit Facility
Variable rate (as a percent)	1.00%
Effective interest rate (as a percent)	9.25%

COMMITMENTS AND CONTINGENCIES - Future aggregate annual principal payments on all long-term debt (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Long-term Debt, Fiscal Year Maturity
Remainder of 2023	$ 297
2024	715
2025	1,398
2026	34,356
2027	176
Thereafter	7,014
Total principal payments	43,956
Less: unamortized original issue discount and debt issuance costs	(219)	$ (300)
Less: Current portion of long-term debt, net of unamortized original issue discount and debt issuance costs	(557)	(551)
Long-term debt, net of unamortized original issue discount and debt issuance costs	$ 43,180	$ 51,434

COMMITMENTS AND CONTINGENCIES - Defined Contribution Plans Narratives (Details) - United States - USD ($)		3 Months Ended		6 Months Ended
	Jan. 01, 2018	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Defined Contribution Plan
Employer discretionary matching		$ 0	$ 0	$ 0	$ 0
Employer contributions		$ 200,000	$ 200,000	$ 500,000	$ 400,000
Maximum
Defined Contribution Plan
Employer contribution (as a percent) (up to)	4.50%

STOCK INCENTIVE PLANS - 2009 and 2019 Stock Option Plan Narratives (Details) - shares	1 Months Ended
	Apr. 30, 2019	Jan. 31, 2018	Nov. 09, 2021	Sep. 30, 2021	Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award
Shares authorized (in shares)	25,204,250
The 2009 Option Plan
Share-based Compensation Arrangement by Share-based Payment Award
Shares authorized (in shares)		17,030,280			16,495,150
Additional shares authorized (in shares)		535,130
The 2019 Option Plan
Share-based Compensation Arrangement by Share-based Payment Award
Additional shares authorized (in shares)	8,173,970
The 2019 Option Plan \| Common Class A
Share-based Compensation Arrangement by Share-based Payment Award
Shares authorized (in shares)			16,856,770	4,339,690
The 2019 Option Plan \| Common Stock, LT50
Share-based Compensation Arrangement by Share-based Payment Award
Shares authorized (in shares)			16,856,770
The 2019 Option Plan \| Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award
Shares authorized (in shares)				8,679,380
The 2019 Option Plan \| Restricted stock units \| Common Stock, LT50
Share-based Compensation Arrangement by Share-based Payment Award
Shares authorized (in shares)				4,339,690

STOCK INCENTIVE PLANS - 2021 Incentive Plan and Matching Plan Narratives (Details) - USD ($) $ / shares in Units, $ in Millions			3 Months Ended		6 Months Ended
	Jun. 14, 2023	Jun. 14, 2022	Jun. 30, 2023	Jun. 14, 2022	Jun. 30, 2023	Jun. 14, 2022	Dec. 31, 2022	Jan. 01, 2022	Nov. 30, 2021
2021 Incentive Plan \| Common Class A
Share-based Compensation Arrangement by Share-based Payment Award
Shares reserved for future issuance (in shares)			22,282,735		22,282,735		17,336,973		11,676,932
2021 Incentive Plan \| Common Class A \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award
Shares reserved for future issuance (in shares)									87,576,990
Annual increase in shares reserved for future issuance (as a percent)								6.00%
Matching shares
Share-based Compensation Arrangement by Share-based Payment Award
Employer share match rate (as a percent)			1.50%		1.50%
Matching shares \| Common Class A
Share-based Compensation Arrangement by Share-based Payment Award
Number of shares purchased (in shares)	140,158	67,946
Shares purchase price (in dollars per share)	$ 6.97	$ 17.42		$ 17.42		$ 17.42
Cash proceeds	$ 1.0	$ 1.2
Options granted (in shares)				3,576		3,576
Matching Plan 1/20th Share Issuance \| Common Class A
Share-based Compensation Arrangement by Share-based Payment Award
Number of shares purchased (in shares)			20,748		36,846
Shares withheld from common stock issued to pay employee payroll taxes (in shares)			6,817
Matching Plan - Discretionary Contributions \| Common Class A
Share-based Compensation Arrangement by Share-based Payment Award
Number of shares purchased (in shares)			75,311		75,311
Shares withheld from common stock issued to pay employee payroll taxes (in shares)			35,391		35,391

STOCK INCENTIVE PLANS - RSU Narratives (Details) - Restricted stock units - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award
Vesting period (in years)	8 years
Share-based compensation expense not yet recognized	$ 177.8	$ 204.2
Share-based compensation not yet recognized, recognition period (in years)	5 years 9 months 18 days	6 years 2 months 23 days
Common Class A
Share-based Compensation Arrangement by Share-based Payment Award
Granted (in shares)	55,731
Vested (in shares)	266,381
Common Class A \| 2021 Stock Plan
Share-based Compensation Arrangement by Share-based Payment Award
Granted (in shares)	55,731
Vested (in shares)	24,792

STOCK INCENTIVE PLANS - RSU Rollforward (Details)	6 Months Ended
STOCK INCENTIVE PLANS - RSU Rollforward (Details)	Jun. 30, 2023 $ / shares shares
Weighted average grant date fair value per share
Beginning balance (in dollars per share) \| $ / shares	$ 33.88
Granted (in dollars per share) \| $ / shares	8.17
Vested (in dollars per share) \| $ / shares	32.65
Cancelled/forfeited/expired (in dollars per share) \| $ / shares	40.92
Ending balance (in dollars per share) \| $ / shares	$ 33.71
Restricted stock units \| Common Class A
RSU Rollforward
Beginning balance (in shares)	3,379,657
Granted (in shares)	55,731
Vested (in shares)	(266,381)
Cancelled/forfeited/expired (in shares)	(100,709)
Ending balance (in shares)	3,068,298
Restricted stock units \| Common Stock, LT50
RSU Rollforward
Beginning balance (in shares)	3,304,643
Granted (in shares)	0
Vested (in shares)	(238,898)
Cancelled/forfeited/expired (in shares)	(100,709)
Ending balance (in shares)	2,965,036

STOCK INCENTIVE PLANS - Stock Option Narratives (Details) - USD ($) $ in Millions	6 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award
Intrinsic value of options exercised	$ 0.7	$ 7.8
Intrinsic value of options outstanding	39.9		$ 46.0
Proceeds from issuance of common stock on exercise of stock options	0.1	$ 0.5
Stock options
Share-based Compensation Arrangement by Share-based Payment Award
Share-based compensation expense not yet recognized	$ 6.0		$ 8.1
Share-based compensation not yet recognized, recognition period (in years)	11 months 23 days		1 year 2 months 15 days
Stock options \| Common stock
Share-based Compensation Arrangement by Share-based Payment Award
Shares repurchased (in shares)	0	0
Stock options \| The 2019 Option Plan
Share-based Compensation Arrangement by Share-based Payment Award
Vesting period (in years)	4 years
Stock options \| The 2009 Option Plan
Share-based Compensation Arrangement by Share-based Payment Award
Vesting period (in years)	4 years
Stock options \| Ten Percent Holder \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award
Purchase price as a percentage of common stock (as a percent)	110.00%
Stock options \| Other Than Ten Percent Holder
Share-based Compensation Arrangement by Share-based Payment Award
Purchase price as a percentage of common stock (as a percent)	100.00%
Stock options \| Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award
Shares subject to repurchase related to stock options early exercised and not yet vested (in shares)	584,037		813,311
Non Statutory Options
Share-based Compensation Arrangement by Share-based Payment Award
Purchase price as a percentage of common stock (as a percent)	100.00%
Weighted-average stock options \| Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award
Shares subject to repurchase related to stock options early exercised and not yet vested	$ 0.9		$ 1.3

STOCK INCENTIVE PLANS - Stock Option Roll-forward (Details)	6 Months Ended	12 Months Ended
	Jun. 30, 2023 $ / shares shares	Dec. 31, 2022 $ / shares shares
Shares
Beginning balance (in shares) \| shares	6,301,650
Options exercised (in shares) \| shares	(102,865)
Options cancelled/forfeited/expired (in shares) \| shares	(44,789)
Ending balance (in shares) \| shares	6,153,996	6,301,650
Options exercisable (in shares) \| shares	6,024,296
Weighted average exercise price per share
Beginning balance (in dollars per share) \| $ / shares	$ 1.67
Options exercised (in dollars per share) \| $ / shares	1.21
Options cancelled/forfeited/expired (in dollars per share) \| $ / shares	3.40
Ending balance (in dollars per share) \| $ / shares	1.66	$ 1.67
Options exercisable (in dollars per share) \| $ / shares	$ 1.46
Weighted average remaining contractual life, options outstanding (in years)	4 years 7 months 17 days	5 years 2 months 12 days
Weighted average remaining contractual life, options exercisable (in years)	4 years 7 months 2 days

STOCK INCENTIVE PLANS - Stock-Based Compensation by Award Type (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Share-based payment arrangement, expense
Stock-based compensation	$ 11,083	$ 14,048	$ 21,744	$ 28,428
Matching shares
Share-based payment arrangement, expense
Stock-based compensation	1,072	15	1,321	17
Stock options
Share-based payment arrangement, expense
Stock-based compensation	874	993	1,774	1,999
Restricted stock units
Share-based payment arrangement, expense
Stock-based compensation	$ 9,137	$ 13,040	$ 18,649	$ 26,412

STOCK INCENTIVE PLANS - Stock-Based Compensation Income Statement Location (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Share-based payment arrangement, expense
Stock-based compensation expense	$ 10,341	$ 14,048	$ 20,345	$ 28,428
Cost of revenue, net
Share-based payment arrangement, expense
Stock-based compensation expense	3,600	4,704	6,906	9,611
Research and development
Share-based payment arrangement, expense
Stock-based compensation expense	2,455	1,877	4,661	4,298
General and administrative
Share-based payment arrangement, expense
Stock-based compensation expense	2,376	5,463	5,020	10,439
Sales and marketing
Share-based payment arrangement, expense
Stock-based compensation expense	$ 1,910	$ 2,004	$ 3,758	$ 4,080

STOCK INCENTIVE PLANS - Stock-based Compensation Narratives (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award
Stock-based compensation capitalized as software development costs			$ 1,399	$ 618
Software Development
Share-based Compensation Arrangement by Share-based Payment Award
Stock-based compensation capitalized as software development costs	$ 700	$ 300	$ 1,400	$ 600

INCOME TAXES - (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
INCOME TAXES - (Details) - USD ($)	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 376,000	$ 2,065,000	$ 2,201,000	$ 3,697,000
Effective income tax rate (in percent)	3.40%	34.80%	14.60%	31.70%
Accrual for uncertain tax positions	$ 1,300,000		$ 1,300,000		$ 1,200,000
Income tax examination, penalties and interest expense			$ 0		$ 0

NET LOSS PER SHARE - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Numerator
Net loss, basic	$ (11,304)	$ (7,994)	$ (17,249)	$ (15,370)
Net loss, diluted	$ (11,304)	$ (7,994)	$ (17,249)	$ (15,370)
Denominator
Weighted-average shares of common stock used to compute net loss per share, basic (in shares)	82,011,477	80,473,097	81,890,624	80,311,053
Weighted-average shares of common stock used to compute net loss per share, diluted (in shares)	82,011,477	80,473,097	81,890,624	80,311,053
Net loss per share, basic (in dollars per share)	$ (0.14)	$ (0.10)	$ (0.21)	$ (0.19)
Net loss per share, diluted (in dollars per share)	$ (0.14)	$ (0.10)	$ (0.21)	$ (0.19)

NET LOSS PER SHARE - Narratives (Details)	6 Months Ended
NET LOSS PER SHARE - Narratives (Details)	Jun. 30, 2023 vote shares
Common Class A
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Voting right per share (vote)	1
Shares converted (in shares) \| shares	1
Common Stock, LT10
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Voting right per share (vote)	10
Conversion of stock, notice period (in months)	10 months
Common Stock, LT50
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Voting right per share (vote)	50
Conversion of stock, notice period (in months)	50 months

NET LOSS PER SHARE - Anti-dilutive Securities (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share
Antidilutive securities (in shares)	4,061,849	5,424,961	4,213,466	6,072,230
Weighted-average stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share
Antidilutive securities (in shares)	4,061,602	5,418,741	4,213,114	6,065,482
Matching shares
Antidilutive Securities Excluded from Computation of Earnings Per Share
Antidilutive securities (in shares)	247	6,220	352	6,748

EQUITY (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
EQUITY (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	May 10, 2022
Equity, Class of Treasury Stock [Line Items]
Repurchases of early exercised stock options	$ 6	$ 16	$ 13	$ 20
2022 Share Repurchase Program \| Class A common stock
Equity, Class of Treasury Stock [Line Items]
Shares authorized for repurchase					$ 50,000
Shares repurchased (in shares)	504,493		504,493
Repurchases of early exercised stock options	$ 3,000		$ 3,000